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Riassunto  
 
L’argomento della mia tesi di dottorato è stato lo studio del ruolo funzionale della 
proteina CtBP1-S/BARS (C-terminal binding protein 1-short form/ brefeldin A ADP-
ribosylation substrate; chiamata BARS per semplicità) nei processi di fissione delle 
membrane intracellulari. La fissione delle membrane è un processo richiesto sia 
durante la formazione delle vescicole di trasporto sia durante la divisione cellulare. Il 
complesso del Golgi rappresenta uno degli organelli cellulari con maggior numero di 
processi di fissione delle membrane ed è quindi usato come modello per studiare tale 
processo.  
Il complesso di Golgi è stato scoperto nel 1898 dall’italiano Camillo Golgi mentre era 
alla ricerca di un metodo per colorare il tessuto nervoso, (Golgi C.1898). La sua reale 
esistenza è stata dibattuta per anni, fino agli anni ’50 quando è stata introdotta la 
microscopia elettronica nella ricerca biologica, che ha risolto tale controversia (Dalton 
and Felix, 1954). 
Il complesso di Golgi è un organello costituito da cisterne membranose appiattite 
impilate l’una sull’altra e connesse tra loro da tubuli. Funzionalmente può essere 
suddiviso in tre compartimenti principali: il cis, il medial e il trans (Farquar and Palade 
1981). E’ un organello essenziale per la biosintesi dei lipidi e per il processamento e 
lo smistamento di proteine; rappresenta, infatti, la stazione centrale lungo il pathway 
secretorio. Riceve proteine neo sintetizzate dal reticolo endoplasmatico (RE) e le 
ridistribuisce verso le loro destinazioni finali come ad esempio la membrana 
plasmatica, gli endosomi o i lisosomi, svolgendo quindi un ruolo centrale nel traffico 
intracellulare (Keller and Simons, 1997).  
Il traffico intracellulare è quel processo per cui a partire da una membrana di un 
organello si formano, per fissione, vescicole che contengono proteine e/o lipidi 
(cargo) diretti verso i compartimenti cellulari dove svolgeranno le loro funzioni. Il 
processo di fissione, nello specifico, è basato sulla formazione delle suddette 
vescicole di trasporto, contenenti cargo, a partire da una membrana appiattita, la 
quale va incontro a budding o gemmazione, elongazione, costrizione ed infine 
fissione con il rilascio delle vescicole di trasporto libere. La fissione delle membrane 
è quindi un processo cellulare fondamentale alla base sia del traffico intracellulare 
che della frammentazione delle membrane del Golgi in mitosi, uno step 
fondamentale per la regolazione del ciclo cellulare.  
Nel laboratorio della Dr.ssa Daniela Corda, dove ho svolto il mio progetto di 
dottorato, è stato dimostrato il ruolo della proteina BARS in diversi processi di 
fissione cellulare, in particolare nella macropinocitosi (Liberali et al., 2008), nella 
pinocitosi, durante la formazione di vescicole di trasporto dal trans-Golgi network 
(TGN) dirette verso la membrana plasmatica basolaterale (chiamate post-Golgi 
carriers, PGCs; Bonazzi et al., 2005, Valente et al., 2012), durante la formazione di 
vescicole ricoperte di COPI dirette dal cis-Golgi verso il RE (Yang et al., 2005) ed 
infine nella ripartizione dell’apparato di Golgi tra le due cellule figlie durante la fase 
G2 del ciclo cellulare (Hidalgo Carcedo et al., 2004, Colanzi et al., 2007).  
BARS appartiene alla famiglia delle C-terminal binding proteins (CtBPs).  
Le CtBPs sono proteine aventi due funzioni ben definite: co-repressori della 
trascrizione nel nucleo, e regolatori della fissione delle membrane. 
BARS infatti è coinvolta sia in processi di fissione, nel citoplasma, sia 
nell’espressione di geni coinvolti in apoptosi e nella trasformazione di cellule da 
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epiteliali a mesenchimali (Corda et al., 2006; Nardini et al., 2003; Chinnadurai, 2009; 
Grooteclaes et al., 2003). 
La fissione delle membrane è regolata da diversi meccanismi, molti dei quali sono 
stati ampiamente studiati e caratterizzati a livello molecolare.  
Il meccanismo meglio studiato e caratterizzato è quello regolato dalla proteina 
dinamina, una GTPasi che si assembla nel sito di costrizione della vescicola durante 
la fase di gemmazione per poi, in seguito all’idrolisi del GTP subire un cambio 
conformazionale tale da indurre la fissione e il successivo rilascio della vescicola 
(Hinshaw et al., 2000). 
Altri processi di fissione sono indotti dall’inserimento in membrana di porzioni 
idrofobiche di proteine contenenti α-eliche anfipatiche. L’inserimento di queste 
porzioni idrofobiche nel doppio strato lipidico induce una curvatura di membrana 
seguita da fissione. Esempi di proteine che agiscono attraverso questo meccanismo 
sono Arf1 e Sar1, proteine implicate nella fissione di vescicole di trasporto ricoperte 
da COPI e COPII, rispettivamente (Boucrot et al., 2012; Lee et al., 2005; Godi et al., 
1999). 
Il meccanismo di fissione regolato da BARS meglio caratterizzato a livello molecolare 
è quello richiesto durante la formazione di vescicole di trasporto dal TGN e dirette 
verso la membrana basolaterale, chiamate vescicole post-Golgi (post-Golgi carriers; 
PGCs) (Bonazzi et al., 2005, Valente et al., 2012). 
Nel laboratorio della Dr.ssa Corda è stato identificato il complesso multiproteico in cui 
BARS agisce per indurre la fissione. Tale complesso comprende BARS e la 
phosphatidylinositol 4-chinasi tipo IIIβ (PI4KIIIβ) legate tra di loro attraverso la 
proteina 14-3-3γ. Questo complesso si assembla e disassembla dinamicamente 
sotto il controllo di altre due kinasi, PKD che fosforila PI4KIIIβ e PAK che fosforila 
BARS. Questi due eventi di fosforilazione stabilizzano la formazione di questo 
complesso, attivandolo durante la formazione dei PGCs sulle membrane del TGN 
(Valente et all 2012). Questo complesso induce fissione delle membrane attraverso il 
reclutamento e l’attivazione di una classe di enzimi capace di modificare la 
composizione lipidica nel sito di fissione.  
Durante il dottorato ho contribuito ad identificare una specifica classe di enzimi, 
aciltransferasi dell’acido lisofosfatidico (lysophosphatidic acid acyltransferase; 
LPAAT) come componente enzimatico essenziale del complesso proteico regolato 
da BARS per indurre la fissione delle membrane del TGN. La famiglia delle LPAAT 
comprende 11 isoforme (Yamashita et al., 2014; Shindou et al., 2013). Io ho 
contribuito a identificare l’isoforma delta come quella capace specificamente di 
legare BARS e di essere attivata enzimaticamente da BARS quando è in complesso 
con PI4KIIIβ e 14-3-3γ.  
LPAATδ è un enzima capace di catalizzare l’incorporazione di un gruppo acilico dall’ 
Acil-Coenzyme A (acilCoA) all’acido lisofosfatidico per formare acido fosfatidico 
(phosphatidic acid; PA). La sintesi di acido lisofosfatidico (LPA) nel lato citosolico del 
doppio strato lipidico delle membrane attraverso la sua forma a cuneo è stato 
proposto facilitare il processo di gemmazione/ tubulazione, viceversa, la sintesi di PA 
attraverso la sua forma conica, destabilizza tali tubuli promuovendone la loro fissione 
in vescicole di trasporto. 
Durante il mio dottorato ho contribuito a studiare il ruolo funzionale dell’interazione 
tra BARS e la LPAATδ nei processi di fissione delle membrane di Golgi regolate da 
BARS.  
Nella prima parte della mia tesi riassumo i dati ottenuti sullo studio del legame, a 
livello molecolare, tra BARS e LPAATδ e di come questo legame sia importante per 
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la formazione di vescicole di trasporto dirette specificamente verso la membrana 
basolaterale e non verso quella apicale. Nello specifico, l’attività enzimatica di 
LPAATδ è importante nel processo di fissione. Infatti, l’inibizione della sua attività 
enzimatica genera lunghi tubuli che originano dalle membrane del TGN per 
gemmazione ma che sono incapaci di fissionare e generare vescicole di trasporto. 
BARS, nel complesso proteico in precedenza identificato (Valente et al., 2012) 
stimola l’attività enzimatica di LPAATδ. Tale stimolazione induce un aumento della 
sintesi di PA a livello del TGN (dove tutto il complesso proteico localizza) 
promuovendo la fissione dei PGCs diretti verso la membrana basolaterale. 
Nella seconda parte della mia tesi, mi focalizzo sulla fissione delle membrane del 
Golgi regolata da BARS in mitosi (Hidalgo Carcedo et al., 2004; Colanzi et al., 2007). 
La mitosi o divisione cellulare richiede un’accurata duplicazione e segregazione del 
contenuto cellulare, che include non solo il genoma, ma anche gli organelli 
intracellulari.  
Nel laboratorio della Dr.ssa Corda è stato dimostrato come la corretta ripartizione 
dell’apparato di Golgi sia una fase cruciale nella divisione cellulare. La prima fase 
della frammentazione del Golgi avviene in G2 e prevede la rottura dei tubuli che 
tengono unite le diverse pile di cisterne (stacks) del Golgi tra di loro, in modo da 
generare stacks isolati dispersi nel citoplasma. Questo processo è necessario per la 
transizione dalla fase G2 alla fase M del ciclo cellulare ed è regolata dalla fissione 
delle membrane del Golgi mediato da BARS. L’inibizione di BARS causa un potente 
e prolungato blocco del ciclo cellulare in fase G2. Come BARS regola e coordina la 
transizione G2-M non è noto, per tale motivo l’identificazione molecolare del suo 
meccanismo d’azione è fondamentale per il controllo del ciclo cellulare. 
Una delle caratteristiche principali delle cellule tumorali è la loro incontrollata 
proliferazione. Diversi sono gli agenti chemioterapici agenti sui processi regolatori 
della mitosi attualmente usati. Tuttavia per ovviare alla citotossicità e alla farmaco-
resistenza di alcuni di questi trattamenti è importante identificare nuovi possibili 
bersagli molecolari. L’identificazione di composti/ molecole capaci di modulare 
l’attività di BARS o di un suo interattore/i rilevante/i in fissione potrebbe essere usato 
per regolare la proliferazione delle cellule cancerose.  
Tale approccio potrebbe quindi essere alla base di una nuova strategia antitumorale. 
 
 
Ruolo di CtBP1-S/BARS nella fissione delle vescicole di trasporto dal Golgi 
verso la membrana basolaterale (PGCs). 
 
Nel laboratorio della Dott.ssa Corda è stato precedentemente dimostrato che: a) le 
membrane di Golgi isolate da fegato di ratto contengono un’ attività aciltransferasica 
capace di trasferire un gruppo acile dall’AcilCoenzima A all’acido lisofostatidico (LPA) 
per generare acido fosfatidico (PA), tale attività è una aciltransferasi dell’acido 
lisofosfatidico (LPAAT) (Weigert et al., 1999); b) l’aggiunta della proteina BARS 
purificata a membrane di Golgi stimola sia la produzione di PA che la fissione delle 
membrane di Golgi (Weigert et al., 1999); c) i trattamenti che bloccano BARS in una 
conformazione dimerica, incapace di indurre la fissione delle membrane, inibiscono 
anche l’attività aciltransferasica (Weigert et al., 1999; Yang et al., 2005; Colanzi et 
al., 2013); e d) BARS purificata non è un’ aciltransferasi bensì è associata ad 
un’attività aciltransferasica (Gallop et al., 2005). 
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Diversi laboratori hanno dimostrato il ruolo del PA in fissione e questi dati insieme ai 
nostri, sopra elencati, ci hanno portato ad analizzare una possibile interazione tra 
BARS e una LPAAT endogena capace di indurre fissione delle membrane. 
Il genoma umano codifica per 11 diverse LPLAT (lysophospholipids 
acyltransferases), quattro delle quali sono state clonate e caratterizzate come  
LPAAT, cioè capaci specificamente di produrre PA a partire da LPA. Queste LPAAT 
sono; LPAATα, β, γ e δ.  
Nel laboratorio della Dott.ssa Corda è stato dimostrato che tra le 11 diverse LPLAT, 
le LPAATγ, LPAATδ e LPAATη localizzano, almeno in parte, nel complesso di Golgi, 
il compartimento cellulare dove agisce il complesso molecolare di fissione regolato 
da BARS.  
Partendo quindi da questi dati e con l'obiettivo di identificare una LPAAT che potesse 
essere coinvolta nella fissione delle membrane mediata da BARS, ho co-
overespresso, in cellule COS7, BARS con ognuna di queste tre LPAAT (γ, δ e η) 
legate ad un tag flag (sequenza di riconoscimento). Attraverso approcci biochimici 
come ad esempio esperimenti di immunoprecipitazione ho dimostrato che BARS co-
immunoprecipita con LPAATγ e LPAATδ e viceversa ma non con LPAATη. 
Contemporaneamente, Brown ed i suoi colleghi hanno dimostrato che LPAATγ 
localizza nel cis-Golgi ed è importante per il corretto mantenimento della struttura del 
Golgi. In seguito, il laboratorio della Dott.ssa Corda attraverso una collaborazione 
con quello del Dr. Victor Hsu (Harvard Medical School, Boston) ha dimostrato che la 
produzione di PA mediata da LPAATγ promuove la fissione delle vescicole ricoperte 
di COPI dipendente da BARS. 
Per quanto riguarda LPAATδ, è stata dimostrata la sua attività LPAAT nel cervello, 
ma non è noto il suo ruolo funzionale nelle membrane di Golgi. Quindi, ho focalizzato 
i miei studi sull’interazione tra LPAATδ e BARS e sul ruolo funzionale di tale 
interazione nelle membrane del Golgi, nello specifico durante la formazione dei 
PGCs.  
Dal punto di vista strutturale BARS è simile alle D-hydroxyacid deidrogenasi (Nardini 
et al., 2005). Infatti, contiene un dominio di legame al NAD/H chiamato dominio di 
legame ai nucleotidi (Nucleotide binding domain; NBD) responsabile della 
conformazione di BARS; il legame a NBD del NAD/H induce una conformazione 
dimerica di BARS incompatibile con la sua attività di fissione (ma compatibile con 
quella trascrizionale). Al contrario, il legame a NBD di AcilCoA induce una 
conformazione monomerica compatibile con la sua attività di fissione (ma 
incompatibile con quella trascrizionale; Nardini et al., 2005; Liberali et al., 2008; 
Valente et al., 2013; Birts et al., 2013). Un altro importante ligando di BARS è BAC 
(brefeldin A ADP rybosilated conjugate), un metabolita della brefeldina A che blocca 
BARS nella sua forma dimerica e quindi inattiva in fissione (Colanzi et al., 2013). 
Quindi, con lo scopo di definire se LPAATδ interagisce selettivamente con la forma 
monomerica di BARS attiva in fissione, ho analizzato attraverso esperimenti di co-
immunoprecipitazione e di pull-down come questi cofattori di BARS ne influenzano la 
sua interazione con LPAATδ. Ho dimostrato che il legame di BARS a BAC ed in 
particolare l’ADP ribosilazione di BARS, abolisce quasi completamente l’interazione 
tra BARS e LPAATδ, indicando che BARS lega LPAATδ nella sua forma 
monomerica attiva in fissione. 
In seguito, ho analizzato il ruolo funzionale di questa interazione durante la 
formazione dei PGCs dipendente da BARS utilizzando un saggio ben caratterizzato 
nel laboratorio della Dott.ssa Corda. Tale saggio prevede l’utilizzo, come marker del 
traffico, di un mutante temperatura sensibile della glicoproteina del virus della 
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stomatite vescicolare (VSVG). Tale proteina dopo essere stata sintetizzata nel RE è 
trasportata nel Golgi e successivamente viene incorporata nei PGCs che dal TGN 
sono diretti verso la membrana basolaterale. Questi diversi steps di trasporto 
possono essere sincronizzati attraverso specifici blocchi di temperatura: la VSVG a 
40°C è bloccata nel RE, a 20°C è bloccata nel TGN e a 32°C viene incorporata nei 
PGCs e diretta verso la membrana plasmatica (PM). Attraverso l’utilizzo della 
microscopia a fluorescenza tale traffico di VSVG all’interno della cellula può essere 
visualizzato e  quantificato. 
Con il fine di analizzare il ruolo di LPAATδ nel traffico di PGCs diretti verso la PM 
(step di trasporto mediato da BARS) ho utilizzato diversi approcci. 
Inizialmente ho inibito cronicamente LPAATδ attraverso uno specifico pool di piccole 
sequenze di RNA (small interfering RNA; siRNAs) capace di inibire la sintesi proteica 
di LPAATδ. Le cellule COS7 così deplete di LPAATδ sono state sottoposte al traffico 
della VSVG. Ho dimostrato che la deplezione di LPAATδ non ha effetto sul traffico di 
VSVG dal RE al Golgi, bensì nel traffico dal TGN verso la PM. Infatti la formazione 
dei PGCs è ridotta del 50% rispetto alle cellule controllo (contenenti livelli endogeni di 
LPAATδ). 
Inoltre, per determinare quale fase durante la formazione dei PGCs è regolata 
dall’attività di LPAATδ (formazione o fissione delle vescicole di trasporto), abbiamo 
analizzato la formazione di questi PGCs mediante video-microscopia, in cellule che 
esprimono GFP-VSVG. In oltre il 30% delle cellule deplete per LPAATδ si formano 
lunghe vescicole di trasporto di forma tubulari contenenti VSVG a partire dalle 
membrane di Golgi incapaci di andare incontro a fissione e quindi di generare PGCs 
diretti verso la PM. Questi risultati indicano che il processo di fissione dei PGCs, e 
non di formazione, è compromesso in cellule deplete per LPAATδ. 
Sulla base di questi dati ho successivamente analizzato se LPAATδ, come BARS, è 
coinvolta solo nel trasporto basolaterale e non in quello apicale. Ho prima analizzato 
il ruolo di LPAATδ nel trasporto di un cargo apicale (p75) e poi ho usato un altro 
cargo basolaterale, l’ LDLr. Il trasporto di LDLr, ma non quello di p75, risente della 
deplezione di LPAATδ indicando che questo enzima è coinvolto, come BARS, solo 
nel trasporto basolaterale e non in quello apicale. 
In parallelo, la Dott.ssa Carmen Valente ha studiato l’attività enzimatica di LPAATδ 
attraverso un saggio specifico per le aciltransferasi che prevede l’utilizzo di estratti 
cellulari, ed in particolare di surnatanti post-nucleari incubati con il [1-14C]-oleoil-CoA 
e l’oleoil-LPA al fine di seguire la formazione del di-oleoil [1-14C]-PA. Tale prodotto di 
reazione viene estratto e separato attraverso una cromatografia su strato sottile 
(TLC) e successivamente quantificato attraverso uno strumento capace di 
quantificare la radioattività, e quindi il prodotto PA, formato in ogni campione del 
saggio. L’attività specifica di LPAATδ è stata determinata attraverso questo saggio 
utilizzando surnatanti post-nucleari preparati da cellule overesprimenti LPAATδ, o 
deplete della LPAATδ o overesprimenti un mutante cataliticamente inattivo della 
LPAATδ (perché incapace di legare il substrato LPA). Estratti ottenuti a partire da 
cellule deplete per LPAATδ con specifici siRNAs o trattati con specifici anticorpi 
contro LPAATδ mostrano una riduzione dell’attività aciltrasferasica mentre estratti 
ottenuti dall’overespressione di LPAATδ mostrano un aumento dell’attività 
aciltrasferasica, aumento che è completamente inibito dall’ anticorpo specifico contro 
LPAATδ.  
Parallelamente, con lo scopo di capire se è l'attività catalitica di LPAATδ importante 
per la formazione dei PGCs, la Dott.ssa Valente ha effettuato esperimenti di rescue 
utilizzando LPAATδwt o un suo mutante LPAATδH96V cataliticamente inattivo perché 
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incapace di legare il substrato LPA. Cellule deplete per LPAATδ, e poi trasfettate in 
modo da indurre l’espressione o della LPAATδwt o della LPAATδH96V, mostrano che 
solo la proteina wild-type ripristina la formazione di PGCs ma non il mutante 
LPAATδH96V cataliticamente inattivo. Questo esperimento indica che è l'attività 
catalitica di LPAATδ, e non la proteina per sé, rilevante nella fissione dei PGCs. 
La Dott.ssa Valente ha poi analizzato se BARS, legandosi a LPAATδ, è capace di 
modularne la sua attività enzimatica, e se questa eventuale regolazione è coinvolta 
nella fissione dei PGCs. Sia la deplezione di BARS che la sua inibizione (attraverso 
un anticorpo specifico contro BARS) comportano una riduzione dell’attività 
enzimatica di LPAATδ e parallelamente inibiscono la fissione dei PGCs. Risultati 
simili sono stati ottenuti anche bloccando BARS nella sua forma dimerica attraverso 
il suo legame a BAC indicando che è la forma monomerica di BARS, attiva in 
fissione, capace di legare e regolare l’attività catalitica di LPAATδ. A conferma di 
questo, l’overespressione di mutanti di BARS inattivi in fissione risultano inibire 
l’attività enzimatica di LPAATδ. 
BARS, ha un ruolo in fissione in complesso con la 14-3-3γ e con la PI4KIIIβ. Quindi, 
è stato analizzato anche il ruolo di queste due proteine nella regolazione dell’attività 
di LPAATδ. La loro deplezione o la loro inibizione riducono l’attività di LPAATδ, 
indicando che la formazione del complesso BARS-14-3-3γ-PI4KIIIβ stabilizza BARS 
nella sua conformazione necessaria al legame con la LPAATδ e quindi di 
conseguenza alla fissione attraverso l’attivazione dell’ LPAATδ e produzione di PA.  
Gli effetti che BARS e LPAATδ hanno sulla fissione dei PGCs che si formano a 
partire dalle membrane del Golgi ci hanno poi portato a pensare che la loro 
interazione avviene specificamente a livello di questo organello. Per confermare 
quindi questa idea abbiamo analizzato la localizzazione di BARS e degli altri 
componenti del suo complesso, LPAATδ, 14-3-3γ e PI4KIIIβ con tecniche di 
immunofluorescenza. Attraverso analisi con microscopia confocale abbiamo 
dimostrato che LPAATδ, 14-3-3γ e PI4KIIIβ localizzano con BARS nei tubuli che 
contengono VSVG e che si formano a partire dal TGN. Infine per dimostrare che 
l’interazione tra BARS e LPAATδ si verifica nelle membrane di Golgi, ho utilizzato 
esperimenti di FRET che rivelano la presenza di due proteine a una distanza 
inferiore o uguale a 8nm, utilizzando CFP-LPAATδ e BARS-YFP. Un segnale di 
FRET, indicatore della loro interazione, aumenta durante il trasporto di VSVG dal 
Golgi verso la PM confermando quindi l’idea che l’interazione tra LPAATδ e BARS 
avviene sul Golgi durante la formazione dei PGCs. 
 
Ruolo di CtBP1-S/BARS nella frammentazione del complesso di Golgi in mitosi. 
 
Nei mammiferi l’apparato di Golgi è composto da 40-100 diverse pile di cisterne 
(stacks) connesse tra loro da tubuli membranosi, questo porta alla formazione del 
Golgi ribbon localizzato nella zona perinucleare della cellula (Dalton and Felix, 1954). 
Un aspetto interessante di questo organello è il suo meccanismo di ereditarietà 
durante la mitosi. Il Golgi in mitosi, infatti, va incontro ad una progressiva e 
reversibile riorganizzazione del ribbon. Il primo step di questa riorganizzazione è la 
fissione dei tubuli che interconnettono gli stacks al fine di raggiungere una corretta 
suddivisione delle membrane del Golgi tra le due cellule figlie. I meccanismi 
molecolari alla base di questo processo sono parzialmente conosciuti e alcune delle 
diverse molecole coinvolte sono state identificate. Tra queste la proteina BARS 
(Hidalgo Carcedo et al., 2004), le proteine strutturali di membrana GRASP65 
(Sutterlin et al., 2002) e GRASP55 (Duran et al., 2008), le chinasi Raf, MEK1, Erk 
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(Acharya et al., 1998), PKD (Kienzle et al., 2012), Cdk1 e Plk1 (Sutterlin et al., 2002). 
Quale sia il meccanismo molecolare di BARS in mitosi non è noto. E’ stato proposto 
che la sua fosforilazione può portare a reclutare proteine/ enzimi importanti per il 
processo di fissione. Meglio conosciuti in mitosi sono i meccanismi di GRASP65 e 
della proteina strutturalmente correlata GRASP55. Queste proteine sono importanti 
nella formazione e nel mantenimento dei tubuli che interconnettono gli stacks 
all’interno del Golgi ribbon. La fosforilazione di GRASP65 in mitosi ne impedisce la 
sua oligomerizzazione, necessaria per il linking delle membrane di Golgi (Wang et 
al., 2005; Wang et al., 2003). L’espressione della porzione C-terminale di GRASP65 
incapace di essere fosforilata causa un ritardo nell’entrata in mitosi, dimostrando 
quindi l’importanza della fosforilazione di GRASP65 per la mitosi. Similmente è stato 
dimostrato che GRASP55 possiede numerosi siti che possono essere fosforilati da 
parte delle chinasi MEK e Erk, fosforilazioni richieste nel processo di frammentazione 
e quindi nella progressione mitotica (Duran et al., 2008). Le kinasi Raf, MEK, ed Erk 
sono state dimostrate essere coinvolte nella frammentazione mitotica del complesso 
di Golgi. In particolare, nella transizione G2/M del ciclo cellulare queste tre kinasi 
sono attivate in modo consequenziale. La deplezione di MEK1 (attraverso specifici 
siRNA) o la sua inibizione attraverso l’uso di specifici inibitori chimici causano un 
ritardo nell’entrata in mitosi (Acharya et al., 1998). Inoltre, recentemente è stato 
dimostrato che PKD, proteina appartenente alla famiglia delle serin/treonin chinasi è 
richiesta per l’entrata delle cellule in mitosi favorendo la rottura delle connessioni tra 
gli stacks nella fase G2 del ciclo cellulare attraverso l’attivazione sequenziale di Raf1, 
MEK e GRASP55 (Kienzle et al., 2012).  
Nella seconda parte della mia tesi ho quindi analizzato il ruolo dei singoli componenti 
del complesso multiproteico di cui BARS fa parte (identificato durante la formazione 
dei PGCs) nella frammentazione del Golgi in mitosi.  
Ho dimostrato, che la deplezione di 14-3-3γ, PI4KIIIβ, LPAATγ e LPAATδ porta al 
blocco dell’entrata delle cellule in mitosi regolata da BARS.  
Inoltre, attraverso approcci biochimici, ho analizzato l’eventuale interazione tra BARS 
e GRASP65 e/o GRASP55 in Interfase e in cellule sincronizzate in fase G2 e fase M 
del ciclo cellulare. Ho dimostrando che BARS interagisce con GRASP55 ma non con 
GRASP65. Successivamente, attraverso esperimenti di immunofluorescenza ho 
dimostrato che la localizzazione di BARS sulle membrane di Golgi non dipende da 
GRASP55 o da GRASP65 bensì da PKD (chinasi responsabile dell’attivazione di 
GRASP55). Infatti, in cellule deplete di GRASP55 o di GRASP65, BARS localizza nel 
Golgi come in cellule controllo, mentre in cellule deplete di PKD, BARS si 
ridistribuisce in parte dal Golgi al citosol. 
Questi dati preliminari suggeriscono che BARS, in mitosi, è coinvolta nel pathway 
che porta all’attivazione di GRASP55. 
Studi futuri sull’identificazione del meccanismo molecolare di BARS nella regolazione 
della divisione dell’apparato di Golgi tra le due cellule figlie in mitosi e quindi l’entrata 
delle cellule in mitosi saranno fondamentali per le importanti conseguenze 
fisiologiche e farmacologiche. Infatti, la sintesi di composti chimici in grado di 
modulare l’attività di BARS o di un suo interattore/i rilevante/i in fissione durante la 
mitosi potrebbe essere usato per regolare la proliferazione delle cellule cancerose 
(caratterizzate da una incontrollata proliferazione cellulare).  
Tale approccio potrebbe quindi essere alla base di una nuova strategia antitumorale. 
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Abstract 
 
This thesis is focused on the role of CtBP1-S/BARS (C-terminal binding protein 1-
short form/ brefeldin A ADP-ribosylation substrate; BARS), in membrane fission, a 
process that is involved in both intracellular membrane trafficking and Golgi 
partitioning during mitosis. 
The Golgi complex is the organelle that was initially described in 1898 by the Italian 
Camillo Golgi, although the real existence of this organelle was debated for decades, 
until the introduction of electron microscopy in the 1950s, which solved the 
controversy. Nowadays, it is well known that the Golgi complex is a cell organelle 
that is involved in many cellular functions, such as intracellular trafficking, post-
translational modification of proteins and lipids, cell partitioning during mitosis, and 
membrane curvature and fission. 
Golgi membrane curvature and the membrane fission that follows is integral to many 
cell functions, such as membrane trafficking and cell partitioning. They are required 
for the formation of intracellular transport carriers, and are controlled by cooperative 
contributions of both lipids and proteins. Membrane fission appears to rely on 
multiple mechanisms, and many of these are mediated by BARS.  
BARS is a dual-function protein that acts as a co-repressor of transcription in the 
nucleus and as a regulator of membrane fission in the cytoplasm. In our laboratory, it 
has been demonstrated that BARS is required in the following processes: 
macropinocytosis, fluid-phase endocytosis, membrane transport from the trans-Golgi 
network (TGN) to the basolateral plasma membrane (PM), COPI vesicle formation, 
and Golgi partitioning that occurs during the G2 phase of the cell cycle (a step that 
controls cell entry into mitosis).  
In the first part of my project, I focused my studies on the fission-inducing property of 
BARS that is required during the formation of basolaterally directed post-Golgi 
carriers. Here, the fission-driving property of BARS is associated with a 
lysophosphatidic acid acyltransferase (LPAAT) activity. I have shown that BARS 
specifically binds LPAATδ, a Golgi-resident enzyme that our laboratory has 
characterised as an LPAAT enzyme that can incorporate acyl-coenzyme A (acylCoA) 
into lysophosphatidic acid (LPA), to form phosphatidic acid (PA). This LPAATδ 
activity is required at the fission step during post-Golgi carrier formation, as shown by 
long tubular carrier precursors that emanate from the Golgi mass but cannot undergo 
fission under LPAATδ inhibition. 
In the second part of my project, I focused on the fission-inducing property of BARS 
in Golgi partitioning during mitosis. Mitosis, or cell division, requires accurate 
duplication and segregation of the cell contents, which includes not only the genome, 
but also the intracellular organelles. Correct inheritance of the Golgi complex is 
crucial for cell division. The Golgi complex is composed of individual stacks of 
cisternae that are laterally connected by tubules, and the cleavage of these tubules in 
G2 phase leads to the break-up of the Golgi ribbon into separate stacks. Treatments 
that block the ﬁssion-inducing activity of BARS inhibit the cleavage of these tubules, 
which results in potent and prolonged cell-cycle block in G2 phase.  
With the aim to better understand and define the molecular mechanisms underlying 
this BARS-mediated Golgi-ribbon unlinking process, I analysed: (i) the role of the 
LPAATδ enzyme, a BARS interactor, in this process; and (ii) whether the BARS-
driven fission machinery interface with the other well-known signalling pathways is 
required for Golgi fragmentation in mitosis. 
 
 20 
 
 
 21 
 
 
CHAPTER 1  
 
INTRODUCTION 
 
1.1 The Golgi complex 
 
1.1.1 The Golgi: discovery and structure 
 
In 1898, at the Medico-Surgical Society of Pavia, Camillo Golgi announced the 
discovery of a new cell organelle, now known as the ‘Golgi apparatus’ or the ‘Golgi 
complex’, or simply, ‘the Golgi’. He defined this organelle as an “internal reticular 
apparatus”, which was based on its ‘net-like’ structure and intracellular location. In 
1873, he developed the so-called “reazione nera” or ‘black reaction’, based on the 
use of silver nitrate to stain the nervous tissue and allowed the view of the Golgi, 
which he defined as a “fine and elegant reticulum within the cell body” (Figure 1.1, A) 
(Golgi,1898). After that, it became clear that this new structure was present in a 
variety of cell types and not only in nervous tissue cells. However, the existence of 
the Golgi as an organ was debated for decades, until the controversy was finally 
resolved by the introduction of electron microscopy (EM) in 1954, when the Golgi 
complex became accepted as a cell organelle (Dalton and Felix, 1954).  
Nowadays, it is well known that the Golgi complex performs essential functions for 
growth, homeostasis and division of eukaryotic cells. It is the central station along the 
secretory pathway, and as such, it receives proteins and lipids synthesised in the 
endoplasmic reticulum (ER) and redistributes them to their final destinations, such as 
lysosomes, endosomes or the plasma membrane (PM). The Golgi complex is also 
important for post-translational modifications, and in particular, the glycosylation of 
proteins and lipids, as they move through the secretory pathway; indeed the Golgi 
has been defined as a ‘carbohydrate factory’ (Farquhar and Palade, 1981).  
In addition, the Golgi recycles selected components back to the ER. The Golgi thus 
serves both as a processing station for newly synthesised glycoproteins and 
glycolipids derived from the ER, and as a filtering system, to separate proteins and 
lipids destined to the PM from those retained in the ER. In mammalian cells, the 
Golgi is typically located around the centrosome, where it remains due to a 
microtubule (MT)-dependent mechanism. The Golgi complex undergoes 
fragmentation when MTs are depolymerised by specific drugs (e.g., nocodazole). 
Schematically, the Golgi consists of flat cisternae that are grouped into several 
stacks (the ‘compact zones’) that are interconnected by tubular networks (the ‘non-
compact zones’), which together form a continuous membranous ribbon (the ‘Golgi 
ribbon’; Figure 1.1, B) that is collected into the pericentriolar space.  
The Golgi is composed of three main compartments: the cis-, medial and trans-Golgi 
(Mellman and Simons, 1992). At the cis-side of the Golgi stacks, there is a tubular 
network that is known as the cis-Golgi network (CGN), which is composed of 
branching tubules that are connected with the cis-most cisterna. The CGN is followed 
by the stack of flat cisternae. Finally, at the trans-side of the stacks, there is another 
structure that appears as a network of branching tubules, the trans-Golgi network 
(TGN). Newly synthesised membrane and secretory proteins coming from the ER 
enter the Golgi through the cis-face, traverse across the stack, and leave via the 
trans-face. The reticulum of tubules that emanate from the trans-most cisterna, which 
are collectively referred to as the TGN, reflects the actual sites of exit (Figure 1.1, C). 
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Figure 1.1. The structure of the Golgi apparatus.  
A. Camillo Golgi’s historical image of the “apparato reticolare interno” of a Purkinjie 
cell [taken from (Golgi, 1898)]. B. Micrograph from NRK cells illustrating a Golgi 
ribbon portion that is comprised of two stacks (1, 2) connected through a non-
compact zone (3) (taken from Polishchuk, 2004). C. Schematic representation of a 
polarised Golgi stack and its sub-compartments (modified from Alberts et al., 2007). 
 
1.1.2 The trans-Golgi network 
 
The TGN is the main sorting station along the secretory pathway, it receives the 
proteins that are processed within the Golgi complex, and it is responsible for their 
sorting into specialised carriers that derive from the TGN membranes, and for their 
delivery to their final destinations (Figure 1.1, C). In this specific compartment, the 
terminal glycosylation of proteins takes place, and the cargo are also packaged into 
membrane carriers that are directed to the PM or to the endosomes or lysosomes. 
The TGN has been considered to be the trans-most cisterna of the Golgi, which was 
also seen to continue into a large tubular network (Griffiths et al., 1989; Clermont et 
al., 1995). In contrast, some reports have considered the TGN as an independent 
organelle (Geuze and Morre, 1991; Reaves and Banting, 1992). Indeed, in some cell 
types, the tubulated TGN is positioned at some distance from the trans aspect of the 
Golgi ribbon.  
Analyses in different mammalian cell types have revealed that the TGN can be 
different in both size and composition (Clermont et al., 1995). Indeed, the 
morphology and the size of the TGN depends on the type and amount of cargo 
proteins that depart from the Golgi complex. This indicates that the structure of the 
           A)                      B)     
                                        C)  
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TGN varies from one cell type to another, and that the TGN is not a static 
compartment of the Golgi, but is constantly undergoing renewal.  
 
1.2 Membrane trafficking at the TGN 
 
Membrane trafficking is the process by which specific compartments and their protein 
contents (the ‘cargo’) move between and within the intracellular sub-compartments. 
This intracellular process involves three main pathways:  
(i) The biosynthetic pathway, by which newly synthesised proteins (with the 
concurrent movement of membrane lipids) destined for secretion are transported 
from the ER to their final destinations (e.g., the PM, endosomes). This pathway 
can be further subdivided into three steps: ER-to-Golgi transport; intra-Golgi 
transport; and TGN-to-PM transport (Lippincott-Schwartz et al., 2001).  
(ii) The endocytic pathway, by which fluid-phase solutes and membrane-bound 
proteins are internalised within membrane-bounded carriers from the 
extracellular environment (Cossart and Sansonetti, 2004; Mellman et al., 1996; 
Pelkmans and Helenius, 2003).  
(iii) The retrograde transport pathway, by which viruses and bacteria enter cells, and 
also for the retrieval of various proteins and lipids to the organelles involved in 
the secretory pathway (Cossart et al., 2004; Pelkmans and Helenius, 2003) 
(Figure 1.2).  
 
The main trafﬁc carriers that operate in these different trafﬁcking pathways can be 
classified into two groups: small round vesicles, and large pleiomorphic carriers 
(LPCs). The first class comprises COPI, COPII and clathrin-dependent vesicles 
(which indicates their protein coat), and they are characterised by a regular spherical 
shape and a diameter of <100 nm (Rothman JE, 2002). LPCs are much larger and 
are more variable in shape than vesicles, whereby the smallest LPCs usually have a 
size of 300 nm to 400 nm, while some of the largest ones can reach several microns 
in length. Many of these carriers appear globular, but they can also be tubular in 
shape during their translocation through the cytosol. Thus LPCs are frequently 
termed as ‘pleiomorphic’ structures. 
Among the LPCs, the best characterised are those that are involved in TGN-to-PM 
transport, and are thus known as post-Golgi carriers (PGCs). The life cycle of these 
PGCs can be schematised in three stages: (1) their formation; (2) their transition 
through the cytosol; and (3) their docking and fusion with the PM (Polishchuk et al., 
2000). The most critical issue regarding PGCs is their formation. The common belief 
was that they result from the budding and release of many small vesicles that then 
undergo homotypic fusion to form large PGCs (Bannykh et al., 1997). However, more 
recently it has become clear that they emerge en bloc from a donor membrane, 
potentially through the aid of a pulling force that is supplied by microtubule-based 
motors (Polishchuk et al., 2003) (Figure 1.3). 
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Figure 1.2 Membrane trafficking at the TGN.  
The major organelles involved in intracellular membrane trafficking are represented. 
Red and blue arrows, membrane movement along the biosynthetic-secretory 
pathway, for anterograde and retrograde transport, respectively; green arrows, 
membrane movements along the endocytic pathway (modified from Alberts et al. 
2007). 
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Figure 1.3 Two possible mechanisms of cargo export from the Golgi complex.  
A. Constitutive cargo proteins exit the TGN within small vesicles (1), which undergo 
homotypic fusion (2) into large cargo containers (3), which can then move off to the 
plasma membrane. Cargo directed to the endosomal-lysosomal system is sorted at 
the TGN into clathrin-coated domains and carriers (4). B. Constitutive cargo proteins 
remain in the bulk of the TGN membranes, and then exit from the Golgi through the 
fission of complex tubular-reticular domains from the rest of the TGN (1). Cargo 
directed to the endosomal-lysosomal system is again sorted at the TGN into clathrin-
coated domains and carriers (2) (modified from Polishchuk et al., 2004). 
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1.3 Membrane fission 
 
Membrane fission is an essential cellular process by which one membrane divides 
into two separate ones. It is required for the formation of transport vesicles during 
membrane traffic, organelle partitioning, and cell division (Corda et al., 2002; 
McNiven and Thompson, 2006). Fission of the membranes of the PM generates 
endocytic vesicles, which transport proteins from the outside medium into the cell 
cytoplasm (Schmid et al., 1997), while fission of ER or Golgi membranes leads to the 
production of carriers for intracellular transport between these organelles, or directed 
to the PM. (Griffiths et al., 2000; Lippincott-Schwartz et al., 2001; Mironov et al., 
1997).  
Membrane curvature followed by membrane fission are the essential steps in the 
formation of all of these transport carriers (Corda et al., 2002) (Figure 1.4). These 
require local distortion and remodelling of the lipid bilayer to create a separate 
membrane-bound compartment, without compromising the integrity of the maternal 
bilayer. The evolution of the initial intact bilayer into two separate membranes must 
proceed via a pathway of intermediate structures (Kozlovsky and Kozlov, 2003). This 
requires both deformation of the membrane monolayers and their transient 
disruption. The deformation is necessary at the early stages of the process, where 
the membrane site adopts a typical neck-like shape, and then at the later stages of 
the formation of the non-bilayer intermediates. The perturbation of membrane 
integrity is an extremely thermodynamically unfavourable event, and thus it most 
probably accompanies the transition from one intermediate structure to another. The 
forces required to drive membrane fission are provided by the protein machinery 
within the cell, and by the lipid composition of the membranes (Chernomordik and 
Kozlov, 2003; Kozlovsky and Kozlov, 2003). 
 
 
 
Figure 1.4 Schematic representations of the steps leading to the formation of 
intracellular transport carriers.  
Buds can be generated from flat membranes, which can then be elongated into 
tubules, and subsequently undergo constriction and fission (from Corda et al., 2002). 
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1.3.1 The role of lipids  
 
Lipids are both structural components of the membrane bilayer and also signalling 
molecules and protein cofactors, the actions of which are exerted in different cell 
compartments. In the secretory pathway, phospholipids represent most of the lipids 
that are synthesised at the ER, and these are then transported to their final 
destinations via the Golgi complex (De Matteis et al., 2002; Kent and Carman, 1999). 
The lipid composition of cell membranes is not homogeneous, and this heterogeneity 
can affect the shape and geometry of the bilayer, which will be involved in protein 
segregation and sorting, as well as in membrane fission (Burger et al., 2000; 
Chernomordik et al., 1995). Moreover, the bilayer is characterised by an asymmetry 
in lipid composition between the internal and external leaflets that can also have a 
role in fission.  
Biological lipids can be classified in three main groups based on their molecular 
shapes and structures: cylindrical (phosphatidylcholine [PC] or other phospholipids), 
conical (or type II; diacylglycerol [DAG], cholesterol), or inverted cones (or type I; 
lysophospholipids) (Figure 1.5, A). When the cytoplasmic leaflet is enriched in cone-
shaped lipids or the luminal/ external leaflet is enriched in inverted-cone lipids, the 
bilayer acquires negative spontaneous curvature. On the other hand, when the 
cytoplasmic monolayer is enriched in inverted-cone-shaped lipids or the lumenal 
external monolayer is enriched in cone-shaped lipids, the membrane acquires 
positive spontaneous curvature (Chernomordik and Zimmerberg, 1995; Corda et al., 
2002). For a flat bilayer, most of the lipids will be cylindrical, as this conformation 
allows optimal packing and minimises the free energy. If non-bilayer lipids are 
introduced into a flat bilayer, some deformation is expected, which will generate a 
bending moment and lead to curvature in the bilayer (Figure 1.5, B).  
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Figure 1.5 Lipid organisation at the fission site. 
A. Schematic representation of the three classes of lipids. Examples of biologically 
relevant lipids classified on the basis of their molecular shapes. B. Schematic 
representation of spontaneous membrane curvature and bending. When the 
cytoplasmic leaflet is enriched in cone-shaped lipids and/ or the lumenal/ external 
leaflet is enriched in inverted-cone lipids, the bilayer acquires negative spontaneous 
curvature and bends towards the organelle lumen or the extracellular space. 
Conversely, when the cytoplasmic leaflet is enriched in inverted-cone lipids and/ or 
the lumenal/ external leaflet is enriched in cone-shaped lipids, the membrane 
acquires positive spontaneous curvature and bends towards the cytoplasm. C. 
Transverse section of the fission site. In transverse section, the geometry of the 
fission site shows positive curvature that better accommodates cone-shaped lipids in 
the lumenal/ external layer and inverted-cone lipids in the cytoplasmic layer (from 
Corda et al., 2002). 
 
 
1.3.1.1 The role of phosphatidic acid in membrane fission 
Phosphatidic acid is an important lipid in membrane fission. It only consists of two 
acyl chains, a phosphate, and glycerol. PA can bind to different proteins, and it is 
involved in several cellular processes (Tigyi and Parrill, 2003; Testerink and Munnik, 
2005). PA is a cone-shaped lipid that can induce negative spontaneous curvature, 
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and its lipid headgroup charge is important in the molecular shape of PA, but also 
influences interactions with other lipids and PA-binding proteins. PA is involved in 
membrane fission because it allows interactions of a membrane-destabilising protein 
with the membrane and can facilitate membrane bending. 
There are three alternative biosynthetic pathways that can lead to the formation of 
PA: (i) phosphorylation of DAG by DAG-kinase; (ii) hydrolysis of phospholipids by 
phospholipase D (PLD); and (iii) acylation of lyso-PA (LPA) by LPA-acyltransferases 
(LPAATs). PA can be also formed by the sequential action of phospholipase C 
(PLC), which forms DAG, and DAG kinase (DGK), which converts DAG to PA. 
Moreover, PA can be dephosphorylated by PA-phosphatases, to form DAG (Corda et 
al., 2002). PA and DAG have been shown to be in dynamic equilibrium, and this 
mechanism can affect the composition and curvature of both of the leaflets of the 
bilayer (Brindley and Waggoner, 1998). PA is also formed by the breakdown of other 
phospholipids, and in particular by the activity of phosphatidylcholine (PC)-specific 
phospholipase D (PLD). It has been reported that PLD-induced increases in PA 
levels can stimulate the release of transport carriers from both the TGN and the cis-
Golgi (Chen et al., 1997; Ktistakis et al., 1996; Yang et al., 2008). Conversely, when 
the activity of PLD is inhibited by primary alcohols (e.g., 1-butanol), the intracellular 
PA levels are reduced and the release of carriers is inhibited (Siddhanta et al., 2000; 
Yang et al., 2008).  
As mentioned above, LPA can be converted to PA by LPAATs (Figure 1.6). PA is a 
central phospholipid because it can be metabolised into DAG, then converted into 
triacylglycerol, phosphatidylcholine and phosphatidylethanolamine, and some of 
these are finally changed into phosphatidylserine (Figure 1.6). The other glycerol 
derivative is cytidine diphosphate DAG, which is modified to form PtdIns, 
phosphatidylglycerol, cardiolipin or phosphatidylserine (Figure 1.6).  
There is evidence that LPAATs are involved in membrane trafficking events, because 
the small-molecule antagonist 2,2-methyl-N-(2,4,6,-trime-thoxyphenyl)dodecanamide 
(CI-976) was shown to inhibit a Golgi-associated LPAAT activity (Chambers et al., 
2004; Drecktrah et al., 2003 ). LPAAT inhibition by CI-976 induces Golgi membrane 
tubulation, and this in turn results in enhanced retrograde trafficking to the ER 
(Chambers et al., 2004). The tubulation effect on Golgi membranes after CI-976 
treatment might be explained by the inhibition of an unidentified LPAAT, the activity 
of which contributes to vesicle fission through the production of negative curvature, 
via local PA production (or secondarily, DAG). 
 
 30 
 
 
 
Figure 1.6 Pathways of glycerophospholipid biosynthesis. 
Glycerophospholipids are first synthesised through the de-novo pathway (the 
Kennedy pathway), and then modified through the remodelling pathway (Lands’ 
cycle). Red and blue arrows, acyltransferases and PLA2s, respectively. G3P, glycerol 
3-phosphate; LPC, LPE, LPS, LPI, LPG, and LCL, lyso-PC, lyso-PE, lyso-PS, lyso-
PI, lyso-PG, and lyso-CL, respectively; CDP-DAG, cytidine diphospho-DAG (modified 
from Shindou and Shimizu, 2009). 
 
 
1.3.1.2 The role of diacylglycerol in membrane fission 
Diacylglycerol is also involved in the regulation of membrane fission processes. It is a 
conical lipid that can induce negative membrane curvature (Goni and Alonso, 1999; 
Burger et al., 2000; Shemesh et al., 2003). The enzymes that lead to the production 
of DAG are located on the cytoplasmic face of the cell membranes, so the 
accumulation of DAG bends the membrane towards the lumen. The generation of a 
DAG-enriched domain in the outer leaﬂet of the TGN might be the relevant event in 
PGC formation.  
Diacylglycerol can be produced at the TGN by three possible mechanisms: (i) from 
PC by sphingomyelin synthase, which transfers PC to ceramide, to produce 
sphingomyelin and release DAG (Ichikawa and Hirabayashi, 1998); (ii) from PtdIns4P 
or phosphatidylinositol 4,5-bisphosphate (PtdIns45P2), that can be converted into 
DAG and inositol bisphosphate or trisphosphate via a phosphoinositide-speciﬁc 
phospholipase C (PI-PLC) (Rhee et al., 2001) and; (iii) from phospholipase D (PLD) 
which converts PC into PA, then dephosphorylated by lipid phosphate phosphatase 
(LPP), thus generating DAG (Brindley and Waggoner, 1998; Pyne et al., 2004). 
(Figure 1.7). 
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Figure 1.7 Possible mechanisms regulating the levels of diacylglycerol (DAG) 
at theTGN.  
Diacylglycerol is generated transiently in biological membranes. The possible 
sources of DAG at the TGN are shown. The enzymes thus far localised to the Golgi 
membranes are shown in green. Other enzymes that have roles in DAG metabolism 
and for which the Golgi localisation is controversial are shown in blue. DGK, DAG 
kinase; LPP, lipid phosphate phosphatase; PA, phosphatidic acid; PC, 
phosphatidylcholine; PI, phosphatidylinositol; PI(4)P, phosphatidylinositol 4-
phosphate; PIP5-K, phosphatidylinositol 4-phosphate 5-kinase; PI(4,5)P2, 
phosphatidylinositol 4,5-bisphosphate; PLC, phospholipase C; PLD, phospholipase 
D; SM synthase, sphingomyelin synthase (from Bard and Malhotra, 2006). 
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1.3.2 The role of proteins in membrane fission 
The role of lipids is not sufficient to drive membrane fission; indeed, proteins can 
cooperate with lipids to trigger the severing of membranes. Here I analyse the roles 
of two relevant proteins: PKD and CtBP1-S/BARS. 
 
1.3.2.1 Protein kinase D 
Protein kinase D is a serine/ threonine-specific family of enzymes that consists of 
three isoforms; PKD1/PKCμ, PKD2 and PKD3/PKCν. These contain: (i) zinc-finger-
like cysteine-rich motifs that are involved in recruitment of PKD to the membrane; (ii) 
a PH domain that has an inhibitory role in the regulation of catalytic activity; and (iii) a 
C-terminal catalytic domain. 
It has been demonstrated that PKD is required to form PGCs at the TGN (Baron and 
Malhotra, 2002, Yeaman et al., 2004). The expression of a kinase-inactive form of 
PKD, or of PKD-speciﬁc chemical inhibitors, blocks protein transport from the TGN to 
the PM. Under these conditions, there is tubulation of the TGN, and these tubules 
contain cargo that are speciﬁcally destined to the PM. It appears that when PKD is 
not active, the cell-surface cargo is sorted into budding transport carriers, but they 
cannot detach from the TGN; thus, there is the formation of tubules. Thus PKD is 
required for ﬁssion of transport carriers from the TGN.  
All three PKDs are involved in the transport of proteins that contain basolateral 
sorting signals. The role of PKD on basolaterally directed PGCs fission can be 
explained on the basis that PKD can recruit a generic pool of DAG to the TGN, which 
can induce ﬁssion. After the arrival of the PM-destined cargo and its sorting in the 
TGN, a signalling cascade is activated, through which a PKD-dependent reaction 
increases the local concentration of DAG. The cargo activates a trimeric G-protein 
through a G-protein–coupled receptor. The activated G-protein subunits, β/γ, activate 
PLC, which hydrolyses PtdIns4P to make DAG at the TGN. The generated DAG 
activates TGN-associated PKCη, which then phosphorylates and activates PKD. 
PKD activates PI4-KIIIβ to generate PtdIns4P from PtdIns. The PtdIns4P is 
hydrolysed to produce DAG. This feedback loop increases the local concentration of 
DAG. DAG is prevented from premature consumption, and upon reaching a critical 
concentration, it catalyses membrane ﬁssion. 
 
1.3.2.2 CtBP1-S/BARS 
The C-terminal-binding protein/brefeldin A ADP-ribosylated substrate (CtBP1-
S/BARS) is a member of the CtBP family of proteins (Chinnadurai, 2002). Mammals 
have two CtBP-encoding genes: CtBP1 and CtBP2. The CtBP1 gene encodes two 
splice variant proteins: CtBP1-L (long) and CtBP1-S (short) (Corda et al., 2006), 
which are different because CtBP1-S lacks the first 11 N-terminal amino acids. 
CtBP1-L was identiﬁed as a protein that can bind the C-terminal region of the 
adenovirus E1A oncoprotein (Boyd et al., 1993), while CtBP1-S was identiﬁed as a 
substrate of the ADP ribosylation induced by the fungal toxin BFA, and for this 
reason was named as brefeldin A ADP-ribosylated substrate (BARS) (De Matteis et 
al., 1994).  
CtBP2 has three splice variants: CtBP2-L (Katsanis and Fisher, 1998), CtBP2-S and 
RIBEYE. CtBP2-S lacks the N-terminal nuclear localisation signal (NLS) of CtBP2-L. 
RIBEYE contains a large N-terminal domain unrelated to CtBPs. Moreover, CtBP2-L 
is the only isoform that contains a NLS (Verger et al., 2006) (Figure 1.8). 
The CtBP1-L and BARS isoforms localise into the nucleus and in the cytosol. CtBP2-
L has a predominantly nuclear localisation, while CtBP2-S has a cytosolic localisation 
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(Verger et al., 2006). CtBP1-L and CtBP2-L were characterised as important 
transcriptional corepressors (Chinnadurai, 2002), while RIBEYE was identified 
independently and cloned on the basis of its localisation in synaptic ribbons (Schmitz 
et al., 2000).  
 
 
 
 
 
Figure 1.8 The CtBP family proteins. 
Schematic representation of the sequences of the CtBP family of proteins. CtBP1-L 
and CtBP1-S/BARS are the alternative splice variants of the CtBP1 gene; CtBP2-L, 
CtBP2-S and Ribeye are alternative splice variants of the CtBP2 gene. The region 
conserved in all of the CtBPs is shown in dark blue. This includes a dehydrogenase 
homology region (D2-HDH) that has weak but significant similarity to the D-
stereoisomer-specific 2-hydroxyacid NAD dependent dehydrogenases (Nardini et al., 
2003). CtBP2-L is the only isoform of the CtBPs that has a nuclear localisation signal 
(NLS; green) (Verger et al., 2006). 
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1.4 Structure and regulation of BARS 
 
The truncated form of the rat protein BARS (Figure 1.9 B), has been crystallised with 
NAD(H) (Nardini et al., 2003). Its structure is similar to that of the D-stereoisomer-
specific-2-hydroxyacid NAD-dehydrogenases (Kumar et al., 2002; Nardini et al., 
2003). 
The BARS:NAD(H) complex forms an homodimer, where each BARS monomer 
consists of two domains, the nucleotide-binding domain (NBD; residues 113-308) 
and the substrate-binding domain (SBD; residues 1-112 and 309-350) (Figure 1.9, 
A). The NBD contains the residues for NAD+ binding, while the SBD is able to bind 
the PxDLS sequence (Nardini et al., 2003). Structural modelling and binding studies 
have shown that BARS can bind NAD(H) and long-chain acyl-CoAs in the same site. 
This analysis suggested that when BARS binds NAD(H) it is in a ‘closed 
conformation/ dimerisation’, while its binding with acyl-CoA induces an ‘open 
conformation/ monomerisation’ (Nardini et al., 2003; Nardini et al., 2009). This 
mechanism represents a switch between the two relevant roles of BARS: 
transcriptional corepressor in the nucleus and regulator of membrane fission in the 
cytoplasm.  
Indeed, BARS can act both in transcription and in membrane fission and these 
activities are regulated by different co-factors. BARS can also shuttle between the 
nucleus and the cytoplasm, and the regulation of this movement can be due to post-
translational modiﬁcations, protein binding, and/or the formation of multiprotein 
complexes (Figure 1.10). 
The two cofactors, acyl-CoAs and NAD(H), can bind BARS in the same pocket 
(Nardini et al., 2003) and this induces the structural change that is connected to the 
change in BARS function. NAD(H) stabilises the dimer, and the interaction with 
PxDLS-containing proteins is increased. At the same time, the effect of NAD(H) is 
also to decrease the interaction between some non-PxDLS-containing proteins and 
BARS (Mirnezami et al., 2003). Acyl-CoAs favour the interactions between BARS 
and ARFGAP1, which promotes membrane fission, while NAD(H) inhibits this 
interaction.  
Secondly, as mentioned above, BARS can be regulated by its interactions with other 
proteins, including CtBP2, transcription factors, and neuronal nitric oxide synthase 
(nNOS) (Figure 1.10). BARS and CtBP2 can homodimerise and heterodimerise, and 
it has been demonstrated that this influences the re-distribution of BARS from the 
cytosol to the nucleus(Verger et al., 2006).  
Finally, BARS is regulated by post-translational modiﬁcations, and in particular by 
phosphorylation and SUMOylation (Figure 1.10). BARS can be phosphorylated on 
different residues by different kinases: at Ser422 by the homeodomain-interacting 
protein kinase-2 (HIPK2) and c-Jun NH2-terminal kinase 1 (JNK1), at the Thr176 by 
Akt1 (Merrill et al., 2010; Figure 1.10), at Ser158 by AMP-activated protein kinase 
(AMPK) (Kim et al., 2013; Figure 1.10), and at Ser147 by PAK1. All of these 
phosphorylation events have two important effects: they block BARS co-repressor 
activity (Barnes et al., 2003), and change its oligomerisation status, shifting it towards 
the monomeric state that is active in membrane ﬁssion (Liberali et al., 2008; Valente 
et al., 2012). 
Conversely, the SUMOylation of BARS at Lys428, leads to nuclear retention and is 
critical for the corepressor activity of BARS (Kagey et al., 2003; Lin et al., 2003).  
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Figure 1.9 Structure of BARS 
A. Ribbon diagram of a truncated form of BARS (lacking the C-terminal segment; t-
BARS) as a dimer bound in its interdomain cleft to NAD(H) (shown in black). Light 
green/ dark green, SBD; orange/ red, NBD; light/dark colouring to illustrate individual 
BARS molecules. B. Amino-acid sequence of C-terminal portion of BARS. In yellow 
the ‘disorder promoting residues’ are highlighted. 
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Figure 1.10 CtBP1/BARS: mechanisms of its functional switch. 
Representative scheme of the CtBP1/BARS functions mediated by a change in its 
oligomerisation state, intracellular localisation, and post-translational modiﬁcations. In 
the cytoplasm, CtBP1/BARS drives membrane ﬁssion in several dynamin-
independent trafﬁcking steps (magenta arrows): ﬂuid-phase endocytosis, 
macropinocytosis, trans-Golgi network (TGN) to basolateral-PM-directed VSVG 
cargo in epithelial cells, retrograde transport of the KDEL receptor to the ER by 
COPI-coated vesicles, fragmentation of the Golgi complex (GC) during mitosis (not 
shown in the scheme). Mechanisms for cytoplasm localisation of CtBP1/BARS might 
depend on binding to the PDZ domain of nNOS, and to AMPK, PAK1, and PAK6 
phosphorylation (see black arrows on the lower right). In the nucleus (N), 
CtBP1/BARS functions in the assembly of multiprotein repressor complexes involved 
in the modulation of gene expression (not shown in the scheme). Mechanisms for 
nuclear localisation of CtBP1/BARS might depend on its oligomerisation with CtBP2, 
binding to transcription factors containing the PxDLS motif, PKA phosphorylation, 
and SUMOylation (see black arrows on the low left). CtBP1/BARS is targeted for 
ubiquitylation followed by proteasome-mediated degradation upon Akt1, JNK1, 
HIPK2, and AMPK phosphorylation (green protein) (from Valente et al, 2013). 
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1.5 The role of BARS in membrane fission 
 
CtBP1/BARS has been shown to be involved in a number of fission processes, as 
described below. 
 
1.5.1 PGC formation 
During membrane trafficking from the TGN to the basolateral PM in epithelial cells, 
PGCs are first extruded, and then fission takes place, to form free carriers directed to 
the PM (Polishchuk et al., 2003). When BARS function is inhibited (e.g., by injection 
of dominant-negative mutants), these PGC tubular precursors do not detach from the 
Golgi complex, but elongate out and retract back into the Golgi mass. Thus the 
fission step of PGC formation is inhibited (Bonazzi et al., 2005; Valente et al., 2012) 
(Figure 1.11A).  
There are several proteins involved in the formation of PGCs, including PI4KIIIβ and 
its product PtdIns4P (Bruns et al., 2002; Godi et al., 2004); Arf (Godi et al., 1999); 
neuronal calcium sensor-1 (NCS-1) (Haynes et al., 2005); the glycolipid-transfer 
protein FAPP2 (D’Angelo et al., 2007; Cao et al., 2009); and GOLPH3 (De Matteis 
and Luini, 2008; Kreitzer et al., 2000).  
Instead, the proteins involved in the fission process are: PKD, which is recruited to 
the TGN by Arf and DAG (Pusapati et al., 2010); myosin II and Rab6 (Miserey-Lenkei 
et al., 2010); and BARS (Bonazzi et al., 2005; Valente et al., 2012).  
In particular our laboratory has demonstrated the role of a novel and crucial protein in 
carrier formation, the 14-3-3γ protein (Valente et al., 2012). This protein bridges 
between PI4KIIIβ and BARS, which together form the tripartite PI4KIIIβ–14-3-3γ(x2)–
BARS core complex, which is involved in BARS-mediated transport from the TGN to 
the PM. 
Moreover, the two other BARS complex components, PKD and PAK1 kinases, can 
stabilise the tripartite complex by reversible phosphorylation, which leads to the 
assembly and disassembly of this dynamic complex (Valente et al., 2012). In 
particular, PKD phosphorylates PI4KIIIβ at Ser294, which stabilises the 14-3-3γ 
binding to PI4KIIIβ (Hausser et al., 2006). The formation of this complex is crucial for 
PGC ﬁssion; indeed manipulations that impair the formation of this complex result in 
long VSVG-containing tubules that elongate out of the Golgi complex, but cannot 
undergo ﬁssion.  
 
1.5.2 Macropinocytosis 
This form of endocytosis results in the formation of large endocytic vesicles, called 
macropinosomes, which originate from actin ruffles at the PM. This ruffling is followed 
by PM invagination and formation of the macropinocytic cup, which then undergoes 
fission of its junction with the PM (Swanson and Watts, 1995). It has been 
demonstrated that the inhibition of BARS does not affect macropinocytic cup 
formation, but instead inhibits the membrane fission process required for 
macropinosome closure, again underlining the specific BARS role in membrane 
fission (Liberali et al., 2008) (Figure 1.11, B).  
 
1.5.3 COPI-coated vesicle formation 
COPI-coated vesicles mediate retrograde transport of the KDEL-receptor from the 
Golgi complex to the ER. When BARS function is inhibited, COPI-coated vesicles 
bud, but do not detach from Golgi cisternae both in vivo and in vitro, consistent with 
fission inhibition (Yang et al., 2005) (Figure 1.11, C). 
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1.5.4 Fluid-phase endocytosis 
Constitutive fluid-phase endocytosis can be monitored by dextran uptake, and it is 
inhibited by BARS impairment (e.g., by injection or expression of a dominant-
negative mutant or a blocking antibody, or by RNA interference) (Bonazzi et al., 
2005).  
 
1.5.5 Golgi fragmentation during mitosis 
During the G2–mitosis transition, the Golgi ribbon is first fragmented into isolated 
stacks of cisternae, and then fragmented into tubulo-vesicular elements. These 
elements are separated into the two main pools that constitute the new Golgi 
complexes in the daughter cells. BARS is necessary for the first stage of this 
fragmentation. Immunodepletion of BARS (e.g., by a polyclonal antibody) results in 
inhibition of mitotic Golgi partitioning and arrest of the cell cycle at the G2 phase 
(Hidalgo Carcedo et al., 2004) (Figure 1.11, D). 
 
 
 
Figure 1.11 BARS-activated membrane fission in different pathways 
A. Effects of BARS inhibition on post-Golgi transport of VSV-G, taken from Bonazzi 
et al. (2005). Representative frames of time-lapse imaging of COS7 cells expressing 
VSV-G-GFP and injected with BARSD355A, a dominant-negative BARS mutant. In the 
VSV-G transport assay, the recombinant BARSD355A mutant was injected during the 
20 °C block (when the VSV-G was trapped on the Golgi complex), and images were 
acquired from 20 min after the shift to 32 °C (temperature block release, allowing exit 
of VSV-G from the Golgi). The images show the formation at and the elongation from 
the Golgi complex of a VSV-G-containing tubule that does not undergo fission. Scale 
bar: 5 μm. B. Effects of BARS inhibition on macropinocytosis, taken from Liberali et 
al. (2008). Representative frames of time-lapse imaging of epidermal growth factor 
(EGF)-induced macropinocytosis in BARS-NBD-YFP (NBD-YFP) expressing cells. To 
detect the newly formed macropinosomes, this stimulation was performed in the 
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presence of TRITC-dextran, as a probe of fluid-phase macropinocytosis. The arrows 
from 90 s to 320 s after EGF stimuli show the formed macropinosome that has not 
sealed. C. Effects of BARS inhibition in COPI vesicle formation, taken from Yang et 
al. (2005). Immunogold labelling of the C terminal inhibitory portion of BARS (BARS-
CTP) show its localisation at the neck of the non-fissioned buds in a COPI vesicle 
reconstitution system using Golgi membranes. Scale bar: 50 nm. D. Effects of BARS 
immunodepletion in mitotic fragmentation of the Golgi complex, taken from Hidalgo 
Carcedo et al. (2004). Quantification of the Golgi fragmentation index in digitonin-
permeabilised NRK cells incubated with mitotic extract (ME), mock-depleted mitotic 
extract (mock), or BARS-depleted mitotic extract without (-) or with 10 μg 
recombinant BARS (BARS). 
 
 
1.6 Golgi behaviour during mitosis 
 
As mentioned above, the Golgi apparatus is composed of individual stacks of flat 
cisternae, called ‘compact zones’ (Dalton and Felix, 1954). These compact zones are 
laterally connected with adjacent stacks by membranous tubular bridges, which are 
referred to as the ‘non-compact zone’ (Rambourg and Clermont, 1990) (Figure 1.1, 
B). Together, these form the membranous system called the ‘Golgi ribbon’, which is 
located in a perinuclear zone around the centrosome, and is maintained there 
through a microtubule (MT)-dependent mechanism (Rambourg and Clermont, 1990).  
There are three models for the biogenesis and inheritance of the Golgi complex: (i) 
de-novo synthesis, where a new copy of the organelle is generated in the absence of 
any existing copy of the organelle; (ii) template assembly/ growth; and (iii) growth 
followed by fission. The organelle inheritance during cell division depends on the 
number of copies of the organelle; indeed, multi-copy organelles can be shared, 
while a single copy organelle can be duplicated and then segregated into daughter 
cells or broken down into multiple pieces. However, a cell can switch from one model 
to another depending on the stage of its life cycle (Lowe and Barr, 2007). Mitotic 
inheritance of the Golgi apparatus involves the progressive and reversible 
disassembly of the Golgi ribbon into dispersed fragments (Figure 1.12), to allow the 
correct partitioning of the Golgi membranes between the two daughter cell (Colanzi 
et al., 2003, Persico et al., 2009).  
During the cell cycle and in particular during G1 and S phase in mammalian cells, the 
Golgi membrane mass increases, probably because the pool of newly synthesised 
proteins increases in the ER, and these are then transported and deposited in the 
Golgi complex.  
At late G2 and during mitosis, there are several structural reorganisations of the 
Golgi apparatus (Shorter et al., 2002) (Figure 1.13). First, at late G2/ early prophase, 
the tubules that interconnect the stacks are severed and this process leads to Golgi 
unlinking into individual or small clusters of stacks. At prometaphase, the Golgi 
stacks undergo unstacking and vesiculation, and mitotic Golgi clusters that comprise 
vesicular and tubular fragments are formed. At telophase, these fragments undergo a 
series of changes that lead to the reassembly of the stacks, and then to the Golgi 
ribbon formation in the two daughter cells.  
Mitotic Golgi ribbon disassembly, and in particular the cleavage of the ribbon into 
stacks, is required for entry into mitosis. This is the reason why it is important to 
determine how Golgi fragmentation controls mitotic progression.  
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Two basic biochemical experimental approaches have been used during these years 
to reconstruct the molecular machinery of Golgi disassembly during mitosis: semi-
intact cell assays and in-vitro disassembly/ reassembly assays. In the semi-intact cell 
assays, the cells are permeabilised with digitonin, washed with 1 M KCl to remove 
endogenous cytosolic proteins and peripheral membrane proteins, and incubated 
with cytosol prepared from interphase or mitosis-arrested cells. After incubation, the 
cells are fixed and analysed by light microscopy or EM. This technique has been 
useful for the identification of the following proteins involved in this Golgi breakdown: 
the fission-inducing protein CtBP1/BARS (Hidalgo Carcedo et al., 2004), the Golgi 
structural proteins GRASP65 (Sutterlin et al., 2002) and GRASP55 (Duran et al., 
2008), the MEK1 kinase (Acharya et al., 1998) and Polo kinase 1 (Plk1; Sutterlin et 
al., 2002) (Figure 1.13). 
The in-vitro Golgi disassembly/ reassembly assay consists of the incubation of 
purified rat liver Golgi stacks with mitotic cytosol. As a result of this incubation, the 
Golgi membranes are dispersed into mitotic Golgi fragments, which can then be 
reassembled into Golgi stacks upon incubation with interphase cytosol or purified 
components. This assay is useful because it is possible to follow, and thus to analyse 
the precise sequence of morphological events, by EM or biochemical analysis.  
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Figure 1.12. Golgi fragmentation begins during the G2 phase of the cell cycle.  
Confocal images of HeLa cells at different cell-cycle phases, grown on coverslips, 
fixed and labelled with Hoecsht for DNA staining, with anti-phosphohistone-H3 
antibody (pH3) to identify early and late G2 cells, and with an anti-GM130 antibody 
for Golgi morphology.  
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Figure 1.13 Golgi ribbon partitioning begins in G2, with the severing of the 
Golgi ribbon into isolated groups of stacks.  
This first step of mitotic Golgi fragmentation (ribbon unlinking) controls G2/M 
transition and requires the activity of MEK1, BARS, GRASP55 and GRASP65. At the 
onset of mitosis, these isolated stacks undergo further disassembly in sequential 
steps: unstacking and vesiculation, leading to the so-called ‘Golgi haze’ during 
metaphase, where the Golgi membranes are completely fragmented. These, 
processes require the activity of the kinases Plk1 and Cdc2, and their targets 
GRASP55 and GRASP65.  
 
1.7 The role of proteins in Golgi partitioning during mitosis 
 
The unlinking of the Golgi ribbon at late G2/ early prophase, and its subsequent 
unstacking and vesiculation, depend on the phosphorylation of Golgi-localised 
proteins by several kinases. A combination of a semi-intact cell assay and the use of 
specific inhibitors and RNA interference (RNAi) have demonstrated that activation of 
the MEK1/ ERK cascade is involved in Golgi fragmentation during G2/M (Acharya et 
al., 1998). MEK1 is recruited to the Golgi ribbon at G2/M, and its depletion or 
inhibition blocks Golgi ribbon unlinking and is responsible for delay of mitotic entry 
(Colanzi et al., 2003). Two ERK kinases have been identified as the strongest 
downstream MEK1 candidates: ERK1c and ERK2. The former localises on the Golgi 
ribbon at late G2/ early prophase. Its depletion inhibits mitotic Golgi fragmentation 
(Shaul and Seger, 2007). The latter, ERK2, is phosphorylated in mitosis by 
GRASP55, a protein that is required for the structural integrity of the Golgi apparatus 
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(Jesch et al., 2001). Moreover, MEK1 can be activated in mitosis by Raf1 (Colanzi et 
al., 2003). Indeed, inhibition of Raf1 inhibits Golgi fragmentation in cell-
permeabilisation assays, whereas addition of the recombinant constitutively activated 
MEK1 rescues the failure in Golgi fragmentation. This suggests that specific Raf1-
mediated activation of MEK1 is required for Golgi complex fragmentation by mitotic 
cytosol (Colanzi et al., 2003). Furthermore, the inhibition of Raf1 by injection of the its 
autoinhibitory domain inhibits cell entry into mitosis by 50%. A further confirmation of 
the role of MEK1 in Golgi fragmentation is that activated MEK1 has been found on 
the Golgi apparatus in late prophase (Colanzi et al., 2003).  
GRASP65 and GRASP55 are the two proteins that have roles in Golgi stacking. 
GRASP65 is phosphorylated during mitosis by two kinases, Plk1 and cyclin-
dependent kinase 1 (Cdk 1); these phosphorylations mediate membrane unstacking 
both in vitro and in vivo (Wang et al., 2003). A model has been proposed according 
to which GRASP65 forms homodimers that can form trans-oligomers with molecules 
residing on adjacent cisternae, to hold them together. This model comes from the 
finding that the formation of oligomers by GRASP65 is regulated by phosphorylation 
(Figure 1.14) (Wang et al., 2005; Wang et al., 2003). The overexpression of the N-
terminal of GRASP65 (which is not mitotically phosphorylated) inhibits Golgi 
unstacking, which results in the formation of more and larger Golgi clusters during 
mitosis (Wang et al., 2005). GRASP55 has complementary roles in Golgi cisternal 
stacking (Xiang and Wang, 2010). 
 
 
 
Figure 1.14 Model of mitotic Golgi cisternal unstacking.  
Schematic representation of mitotic Golgi unstacking. During interphase, GRASP65 
dimers form oligomers with GRASP65 dimers present on adjacent cisternal 
membranes; this mechanism holds the cisternae together (Golgi stacking). During 
mitosis, GRASP65 phosphorylation by the Cdk1/CycB complex and Plk1 kinase 
breaks the GRASP65 oligomers, causing unstacking of the cisternae. At the end of 
mitosis, dephosphorylation of GRASP65 restacks the cisternae (modified from 
Mironov et al., 2008). 
 
In mitosis, the Golgi stacks undergo further fragmentation, which is controlled by 
Cdk1 and Plk1 (Ferrari et al., 2006). For mitotic Golgi disassembly, Cdk1 appears to 
act after MEK1/ ERK-mediated ribbon unlinking, to promote complete vesiculation of 
the Golgi stack (Colanzi et al., 2003). Moreover the depletion of Plk1 by RNAi was 
shown to be required for full Golgi stack vesiculation (Preisinger et al., 2005).  
At the vesiculation step, the Golgi appears as the ‘Golgi haze’ (Misteli and Warren, 
1995a). The mechanism of inheritance between the two daughter cells has been 
explained by two opposing views. The first suggested that the Golgi haze is Golgi 
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proteins that are redistributed into the ER, so the Golgi is inherited together with the 
ER (Zaal et al., 1999). The second view supports the idea that the Golgi apparatus is 
independent of the ER, and in this case the key mechanism of Golgi inheritance is 
the disruption of the membrane-tethering complexes, which is induced by the action 
of mitotic kinases (Shorter and Warren, 2002). These fragments contained in the 
Golgi haze are then partitioned between the two daughter cells through a process 
directed by the mitotic spindle (Shima et al., 1998). The final destination of the mitotic 
Golgi membranes is still not known, but it is clear that the Golgi apparatus is 
reassembled before cytokinesis. Thus, once divided between the daughter cells 
during telophase, the Golgi fragments reassemble and fuse into a fully functional 
Golgi stack.  
 
1.7.1 GRASP65 
GRASP65 is a peripheral membrane protein that is associated with Golgi 
membranes through its N-terminal myristic acid, which is known as the ‘GRASP 
domain’ (residues 1-197), and which includes two PDZ-like domains. The GRASP 
domain is important to form dimers, which associate in trans and links adjacent 
cisternae to form the stacked Golgi (Wang et al., 2005; Wang et al., 2003). The C-
terminal portion of GRASP65 contains the serine-proline-rich (SPR) domain 
(residues 198-446) (Barr et al., 1997) (Figure 1.15), which is phosphorylated at 
multiple sites during mitosis (Preisinger et al., 2005).  
 
 
 
Figure 1.15 Schematic representation of the GRASP65 sequence.  
The N-terminal domain, called the ‘GRASP domain’, comprises two PDZ-like 
domains and the GM130-binding region. The C-terminal domain is rich in 
phosphorylation sites, which are indicated in red. 
 
It has been shown that the microinjection of a GRASP65-blocking antibody into 
mitotic cells blocks Golgi stack formation in the daughter cells. This suggests that 
GRASP65 is required for Golgi stacking (Wang et al., 2008). However, it was later 
demonstrated that GRASP65 might not have a role in cisternal stacking (Sutterlin et 
al., 2005), but in the formation and/or maintenance of the tubules that connect the 
stacks within the Golgi ribbon (Puthenveedu et al., 2006). The C-terminal SPR 
domain of GRASP65 can be phosphorylated by Cdk1 and Plk1 kinases on multiple 
sites. In-vitro experiments have suggested that Cdk1 targets GRASP65 at four 
serine/ threonine residues (S216/ Ser217, T220, S277, S376) (Barr et al., 1997; Lin 
et al., 2000; Wang et al., 2003), while Plk1 can be recruited to Golgi membranes and 
drives the fragmentation of the Golgi complex under mitotic conditions (Preisinger et 
al., 2005; Sengupta and Linstedt, 2010). Furthermore, GRASP65 could be a 
substrate of MEK1/ ERK also in mitosis, although this has not yet been demonstrated 
(Yoshimura et al., 2005). The role of GRASP65 in the Golgi checkpoint has been 
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extensively studied, but there is no clear model on how it regulates Golgi 
fragmentation and mitotic entry. This might either be an effect caused directly by the 
inhibition of GRASP65, or a secondary effect caused by the perturbation of the Golgi 
structure or by the disruption of the signalling cascades that control mitotic entry. 
Indeed, as described above, GRASP65 has a C-terminal domain that is 
phosphorylated at multiple sites during mitosis, which suggests its involvement in 
regulatory functions or structural functions (Preisinger et al., 2005). One of the 
phosphorylation site on GRASP65, serine 277 (S277), has been extensively studied. 
This residue is phosphorylated in vitro by Cdk1/ CycB during mitosis, and this has 
provided clarification of a hypothetical regulatory role of GRASP65 during G2/M 
transition (Yoshimura et al., 2005). However, there are still several points to address 
the role of GRASP65 in the Golgi-related mitotic checkpoint. 
 
1.7.2 GRASP55 
GRASP55 is the second mammalian GRASP homologue (Shorter and Warren, 
1999). In contrast to GRASP65, GRASP55 has been shown to be mitotically 
phosphorylated in vitro by ERK2, a downstream target of MEK1 (Jesch et al., 2001). 
The overexpression of the two GRASP55 phosphorylation-defective mutants (T222, 
225A) inhibit Golgi ribbon unlinking and blocks/ delays G2/M transition (Feinstein and 
Linstedt, 2007). The requirement for GRASP55 in Golgi fragmentation and mitotic 
entry was also demonstrated by Malhotra and colleagues (Duran et al., 2008). They 
showed that also T225 and T249 phosphorylation in the C-terminal of GRASP55 are 
required for both Golgi fragmentation and entry into mitosis. However, several 
parallel studies on the two GRASPs are needed to more fully address their roles in 
Golgi ribbon unlinking. 
 
1.7.3 BARS 
The involvement of BARS in mitotic Golgi partitioning was evaluated through a well-
established assay that reconstitutes the process of Golgi fragmentation in 
permeabilised NRK cells incubated with mitotic cytosol (Acharya et al., 1998). 
Depletion of BARS from mitotic extracts inhibited Golgi fragmentation by more than 
75%. Moreover, the addition of the two dominant-negative mutants of BARS, NBD or 
SBD, to mitotic cytosol resulted in inhibition of Golgi fragmentation. As confirmation 
that this inhibition of Golgi fragmentation was due to a failure in BARS activity, the re-
addition of recombinant BARS to these extracts completely restored the 
fragmentation process (Hidalgo Carcedo et al., 2004).  
The functional role of BARS has also been analysed in living cells, by microinjection 
of an anti-BARS antibody, or the purified recombinant SBD mutant. Both treatments 
inhibited Golgi fragmentation and mitotic entry. Using these inhibitory reagents 
(antibody and SBD) in combination with FRAP analysis, BARS was later shown to 
act through the severing of the tubules that interconnect the Golgi stacks in the Golgi 
ribbon in late G2 (Colanzi et al., 2007). Of note, although the BARS knock-out mouse 
is embryonically lethal, the derived embryonic fibroblasts divide normally.  
However, interference with BARS activity in interphase does not lead to Golgi 
fragmentation (Hidalgo Carcedo et al., 2004), which indicates that the role of BARS 
in fission of Golgi tubules is mitotically regulated and probably acts in concert with 
other proteins. The above-described requirement for Golgi fragmentation for entry 
into mitosis is in agreement with a checkpoint that monitors Golgi fragmentation, to 
allow cell entry into mitosis.  
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1.7.4 PKD 
As mentioned above, PKD is a protein that belongs to a family of serine/ threonine 
kinases. This family is composed of three members: PKD1, PKD2 and PKD3. In 
2002, the involvement of PKD in the fission of vesicles directed to the plasma 
membrane was demonstrated by Baron and Malhotra. Indeed, PKD interacts with 
DAG and is recruited into the TGN, where it is involved in the fission of post-Golgi 
carriers (Liljedahl et al., 2001). Moreover, Kienzle and colleagues (2012) have 
demonstrated that PKD is required also for mitotic entry of HeLa cells, in particular in 
the cleavage of the Golgi interstack connections in late G2 phase of the cell cycle. 
Indeed the depletion of PKD1 and PKD2 by siRNA treatments leads to accumulation 
of cells in G2 phase. Additionally, it has been demonstrated that PKD is required for 
the cleavage of the non-compact zones of the Golgi membranes in G2 phase, which 
prevents cells from entering mitosis. Moreover, mitotic Raf-1 and MEK1 activation 
are blocked after PKD inhibition, which suggests that PKD is involved in Golgi 
partitioning during mitosis in a Raf-1/ MEK1–dependent manner. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1 Materials 
 
DL-dithiothreitol (DTT), bovine serum albumin (BSA), saponin, Tris-[hydroxymethyl]-
aminomethane (Tris), ethylene glycolbis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic 
acid (EGTA), ethylenediaminetetraacetic acid (EDTA), H2PO4, Na2HPO4, NaH2PO4, 
sucrose, brefeldin A (BFA) and reduced L-glutathione were all from Sigma–Aldrich 
(WI, USA). NaCl, HCl, NaOH, KOH, NH4Cl, dimethylsulphoxide (DMSO), methanol 
and chloroform were all from Carlo Erba (Italy). 4-(2-Hydroxy-ethyl)-piperazine-1-
ethanesulfonic acid (Hepes), glycerol, KCl, MgCl2 and CaCl2 were all from Merck 
(Germany). C-Mercaptoethanol was from Fluka (Switzerland). Mowiol was from 
Calbiochem (CA, USA). Paraformaldehyde was from Electron Microscopy Sciences 
(PA, USA). The sources of the other materials used are specified for each procedure.  
 
2.2 Solutions 
 
Phosphate-buffered saline (PBS): 1.5 mM KH2PO4, 8 mM Na2HPO4, 2.7 mM KCl, 
137 mM NaCl, pH 7.4.  
The blocking solution was prepared as follows: 0.5% BSA, 50 mM NH4Cl in PBS, pH 
7.4. Where needed, saponin was added to 0.05% to the preparation. Aliquots of this 
blocking solution were stored at -20 °C.  
The composition of the other solutions used are specified for each procedure. 
 
2.3 Subcloning and mutation of DNA 
 
2.3.1 Materials 
Restriction enzymes were from Amersham Pharmacia Biotech (NJ, USA). T4 DNA 
ligase and DNA molecular size standards were from Gibco/BRL (NY, USA). The 
‘QIAprep Spin Miniprep’ kits and the ‘QIAGEN Plasmid Maxi’ kits were from Qiagen 
(CA, USA). The ‘QuikChange Site-Directed-Mutagenesis’ kits were from Stratagene 
(La Jolla, CA, USA). Tryptone, peptone, yeast extract and agar were from Difco, 
Becton Dickinson (MD, USA). 3-Morpholino-propanesulfonic acid (MOPS), RbCl and 
MnCl2 were from Sigma–Aldrich (WI, USA). 
 
2.3.2 Solutions and media 
Lysogeny broth (LB): 1% (w/v) tryptone peptone, 0.5% (w/v) yeast extract, 1% (w/v) 
NaCl; autoclaved 15 min at 121 °C. 
LB-agar: LB plus 1.5% (w/v) agar: autoclaved 15 min at 121 °C. 
TE (Tris/EDTA) buffer: 10 mM Tris-HCl, 1 mM EDTA, pH 8. 
TAE (Tris/acetic acid/EDTA) buffer (50x, 1.0 l): 242 g Trizma base, 57.1 ml glacial 
acetic acid, 100 ml 500 mM EDTA. 
 
2.3.3 DNA agarose gels 
Agarose gels were prepared by dissolving agarose in TAE buffer and heating in a 
microwave oven. Ethidium bromide was added (to 0.5 μg/ml), and the gels were 
poured and run on an agarose gel apparatus from Bio-Rad Laboratories (UK). DNA 
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standards (0.5 μg) were loaded and used as a reference for approximate estimations 
of the amounts of DNA in the samples. 
 
2.3.4 PCR amplification of DNA inserts 
To amplify specific regions of DNA inserts, PCR was performed by incubating 10 ng 
DNA plasmid as a template in 50 μl 20 mM Tris-HCl, pH 8.8, 10 mM KCl, 2 mM 
MgSO4, 10 mM (NH4)SO4, 0.1% Triton X-100, 0.1 mg/ml nuclease-free BSA, 1 μM 
each oligonucleotide, 200 μM each dNTP, 2.5 U PFU Turbo DNA Polymerase. All of 
the reagents, except the DNA and the oligonucleotides, were from Stratagene (CA, 
USA). The oligonucleotides were from Sigma–Genosys.  
The PCR reaction mixtures were layered with mineral oil (Sigma–Aldrich, WI, USA) 
and subjected to 25 temperature cycles in a programmable thermal cycler (MJ 
Research Inc.). The melting, annealing and elongation temperatures were adjusted 
according to the features of the template and primers. To facilitate the subsequent 
subcloning of the PCR products, the forward and reverse primers were provided with 
restriction sites at their 5’ ends. 
 
2.3.5 Restriction and ligation 
DNA (vectors and inserts) were cut with 5 U/μg of the appropriate restriction 
enzymes in the buffer supplied with each enzyme by Amersham Pharmacia Biotech 
(NJ, USA). After restriction, the enzymes were usually inactivated by incubating them 
at 65 °C to 75 °C for 10 min to 20 min, according to the manufacturer instructions, 
and then the samples were loaded onto 1.0% to 1.4% agarose gels. The bands of 
interest were cut from the gels with a sterile scalpel, and the DNA was extracted from 
these gel samples with the ‘Qiaex II’ extraction kits (Qiagen, CA, USA), according to 
the manufacturer instructions. The DNA was eluted in 10 mM Tris-HCl, pH 8.0. To 
ligate the vector and the insert, ~100 ng of the vector and an ~3-fold molar amount of 
the insert were incubated with 1 U T4 DNA ligase in T4-DNA-ligase buffer 
(Gibco/BRL, UK) for 10 min at room temperature (RT). 
 
2.3.6 DNA mutagenesis 
The DNA (10 ng vector and insert) and 125 ng of the two synthetic oligonucleotide 
primers containing the desired mutations were amplified by PCR, according to the 
manufacturer instructions of the ‘QIAprep Spin Miniprep’ kits (Qiagen, CA, USA). The 
mutagenesis reaction mixtures were layered with mineral oil (Sigma–Aldrich, WI, 
USA), and subjected to 25 temperature cycles in a programmable thermal cycler (MJ 
Research Inc.). The melting, annealing, and elongation temperatures were adjusted 
according to the features of the template and primers. The oligonucleotides were 
from Sigma–Genosys. After the reaction, DpnI endonuclease was added to the 
mixture for 1 h at 37 °C, to digest the parental non-mutated DNA template. The 
products were analysed on agarose gels and the mutations were verified by DNA 
sequencing (BMR Genomics, CRIBI, Padova, Italy) 
 
2.3.7 Transformation of bacteria 
The DNA plasmid of interest (10 ng uncut plasmid, or half of a ligation reaction) was 
added to competent bacteria. After gentle mixing, the bacteria were left on ice for 30 
min, and then heat shocked for 45 s at 42 °C. After the addition of 800 μl LB, the 
bacteria were incubated under continuous shaking (200 rpm) at 37 °C for 45 min. 
The bacteria were plated onto LB agar containing the appropriate selective antibiotic, 
and incubated overnight (O/N), at 37 °C. The next day, an isolated bacterial colony 
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was picked and used to inoculate 2 ml LB containing the appropriate antibiotic. The 
culture was incubated O/N at 37 °C. Sterile glycerol (300 μl; 50%; v/v) was added to 
700 μl of the bacterial culture, which was then stored at -80 °C. 
 
2.3.8 Small-scale preparation of plasmid DNA (minipreps) 
The clones obtained after the transformation of the ligation reaction were usually 
screened using minipreps and subsequent restriction analysis. Isolated bacterial 
colonies were picked and inoculated into 5 ml LB containing the appropriate 
antibiotic. After O/N growth at 37 °C under continuous shaking (200 rpm), 700 μl of 
the cultures was mixed with 300 μl 50% (v/v) sterile glycerol and stored at -80 °C; the 
rest of each culture was chilled on ice and centrifuged 10 min at 4,000x g. The DNA 
was extracted using ‘QIAprep Spin Miniprep’ kits (Qiagen, CA, USA), according to 
the manufacturer instructions, and analysed by restriction analysis and separation on 
agarose gels. 
 
2.3.9 Large-scale preparation of plasmid DNA (maxipreps) 
A small amount of the bacteria transformed with the plasmid of interest was scraped 
from the glycerol stock, inoculated into 2 ml LB containing the appropriate selective 
antibiotic, and grown at 37 °C under continuous shaking (200 rpm) for 6 h to 8 h. This 
pre-culture was used to inoculate 200 ml LB containing the selective antibiotic. After 
an O/N incubation, the bacteria were collected by centrifugation at 6,000 rpm in a 
JA14 rotor (4,000x g) for 10 min at 4 °C, and processed according to the maxi-
plasmid purification protocol of the ‘Qiagen Plasmid Maxi’ kits. The DNA obtained 
was resuspended in TE buffer and stored at -20 °C. 
 
2.4 Expression and purification of recombinant proteins 
 
2.4.1 Solutions 
GST lysis buffer: 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA. 
GST elution buffer: 100 mM Tris-HCl, pH 8.0, 20 mM glutathione, 5 mM DTT. 
Protease inhibitor cocktail (Complete Mini EDTA-free; Roche). 
His lysis buffer: 50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, 10 mM 
imidazole. 
His wash buffer: 50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, 20 mM 
imidazole. 
His elution buffer: 50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, 250 mM 
imidazole. 
 
2.4.2 Expression and purification of GST-tagged proteins 
GST-BARS was purified as described in Valente et al., 2005. 
 
2.4.3 Expression and purification of his-tagged proteins 
His-BARS was purified as described in Valente et al., 2005. 
 
2.5 General biochemical procedures 
 
2.5.1 Materials 
Sodium dodecyl sulphate (SDS), glycine, Trizma base, Ponceau red, 
polyoxyethylenesorbitan monolaurate (Tween-20), ammonium persulphate (APS) 
and N,N,N’,N’-tetramethylethylenediamine (TEMED) were from Sigma–Aldrich 
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(WI,USA). The acrylamide stock solution, at 40% (w/v) acrylamide:bis-acrylamide 
(37.5:1), was from Eurobio (France). Acetic acid was from Carlo Erba (Italy). 
Secondary antibodies conjugated with horse radish peroxidase (HRP) and directed 
against mouse or rabbit IgGs were from Calbiochem (CA, USA). The ECL reagents 
were from Amersham Pharmacia Biotech (NJ, USA). 
 
2.5.2 Solutions 
Running buffer: 25 mM Trizma base, 200 mM glycine, 0.1% (w/v) SDS. 
SDS sample buffer: 62.5 mM Tris-HCl, pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 5% 
(v/v) C-mercaptoethanol and 0.1% (w/v) bromophenol blue. 
Transfer buffer: 25 mM Trizma base, 200 mM glycine, 20% (v/v) methanol. 
TBS: 150 mM NaCl, 20 mM Tris-HCl, pH 7.5. 
TTBS (TBS plus Tween 20): 0.05% (w/v) Tween 20, 150 mM NaCl, 20 mM Tris-HCl, 
pH 7.5. 
Blocking solution for Western blotting: 1% (w/v) BSA in TTBS; 5% skimmed milk in 
TTBS. 
 
2.5.2.1 Assembly of polyacrylamide gel 
Two 16 cm x 18 cm plates were used for standard gels, while two 16 cm x 32 cm 
plates were used for long gels. The plates were assembled to form a chamber using 
two 1.5 mm plastic spacers aligned along the lateral edges of the plates. The plates 
were then fixed using two clamps and mounted onto a plastic base which sealed the 
bottom. All of the materials were from Hoefer Scientific Instruments (Germany). The 
‘running’ polyacrylamide gel was prepared by mixing H2O, 40% (w/v) 
acrylamide:bisacrylamide solution, 1.5 M Tris-HCl, pH 8.8, 10% (w/v) SDS, to have 
the selected concentration of acrylamide in 375 mM Tris-HCl, 0.1% (w/v) SDS. Then, 
0.06% (w/v) APS and 0.06% (v/v) TEMED were added; the solution was mixed and 
poured into the gap between the plates, leaving ~5 cm for the stacking gel. Soon 
after pouring, the gel was covered with a layer of H2O and left at RT for ~2 h. The 
H2O layer was then removed. The ‘stacking’ polyacrylamide gel was prepared by 
mixing H2O, 40% (w/v) acrylamide:bisacrylamide solution, 500 mM Tris-HCl, pH 6.8, 
10% (w/v) SDS, to have 4% (w/v) acrylamide, 125 mM Tris-HCl, 0.1% (w/v) SDS. 
Then, 0.1% (w/v) APS and 0.07% (v/v) TEMED were added, and the solution was 
mixed and poured onto the running gel. Immediately, a 15-well or 10-well comb was 
inserted between the glass sheets and the apparatus was left for 1 h at RT. 
 
2.5.2.2 Evaluation of protein concentration 
Protein concentrations were evaluated using commercially available protein assay 
kits (Bio-Rad Laboratories, UK), according to the manufacturer instructions. 
 
2.5.2.3 Sample preparation and running 
Samples were prepared by adding SDS sample buffer, incubating at 100 °C for 5-10 
min in a multi-block heater (Lab-Line, IL, USA), cooling to RT, briefly centrifuging, 
and finally loading onto the gel. One well was loaded with 5 μl Rainbow recombinant 
protein molecular weight markers (Amersham Pharmacia Biotech, NJ, USA) or with 5 
μg Low Molecular Weight Standards (Bio-Rad Laboratories, UK). The gel was then 
transferred into the electrophoresis apparatus (Hoefer Scientific Instruments, NJ, 
USA), and the electrophoresis was carried out under constant current of 8 mA (for 
O/N runs) or 40 mA (for ~4-h runs). 
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2.5.3 Western blotting 
 
2.5.3.1 Protein transfer onto nitrocellulose 
The polyacrylamide gels were soaked for 15 min in transfer buffer, placed on a sheet 
of 3MM paper (Whatman, NJ, USA) and covered with a nitrocellulose filter 
(Schleicher & Schuell, Germany). The filter was covered with a second sheet of 3MM 
paper, to form a ‘sandwich’, which was subsequently assembled into the blotting 
apparatus (Hoefer Scientific Instruments, NJ, USA). The protein transfer was carried 
out at 500 mA for 4 h or at 125 mA O/N. At the end of the run, the sandwich was 
disassembled, and the nitrocellulose filter was soaked in 0.2% Ponceau red (Sigma-
Aldrich, WI, USA) and 5% (v/v) acetic acid for 5 min, to appropriately visualise the 
protein bands, and then rinsed with 5% acetic acid, to remove excess unbound dye. 
 
2.5.3.2 Probing the nitrocellulose with specific antibodies 
The nitrocellulose filters were cut into strips with a razor blade. The strips containing 
the proteins of interest were incubated in the blocking solution for Western blotting 
plus 1% BSA or 5% milk powder (for ECL-based detection) for 1 h at RT, and then 
with the primary antibody diluted to its working concentration in the blocking solution 
for Western blotting (see Table 2.1, for list of antibodies used in the Western 
blotting). After a 2-3-h incubation at RT, or an O/N incubation at 4 °C, the antibody 
was removed and the strips were washed twice in TTBS, for 10 min each. The strips 
were next incubated for 1 h with the appropriate HRP-conjugated secondary antibody 
diluted in the blocking solution for Western blotting (antirabbit: 1:20,000; anti-mouse: 
1:5,000) and washed twice in TTBS, for 10 min each, and once in TBS for 3 min. 
After washing, the strips were incubated with the ECL reagents, according to the 
manufacturer instructions for ECL-based detection. 
 
2.6 Cell culture 
 
2.6.1 Materials 
African green monkey kidney (COS7), HeLa and Hela CD8+ cells were from 
American Tissue Type Collection (ATTC, USA). HeLa shRNA TRCN0000154917 and 
HeLa shRNA TRCN0000127674 stable cell lines depleted for GRASP65 and 
GRASP55, respectively, were kindly provided by Dr Juan Duran from the Vivek 
Malhotra Laboratory. Dulbecco’s modified Eagle’s medium (DMEM), minimum 
essential medium (MEM), foetal calf serum (FCS), penicillin, streptomycin, trypsin-
EDTA and L-glutamine were all from Gibco/BRL (NY, USA). All of the plastic cell 
culture materials were from Corning (NY, USA). Filters (0.45 μm, 0.20 μm) were from 
Amicon (MA, USA). 
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Table 2.1 List of antibodies used in the Western blotting.  
 
Antibody 
target 
Dilution Animal source Supplier source 
BARS (BC3) 1:100 Mouse Piccini D, IFOM-IEO Milan 
BARS (p502) 1:1000 Rabbit Lab Corda, Ibp, Naples 
PI4KIIIβ 1:1000 Rabbit De Matteis Lab, TIGEM, 
Naples 
14-3-3γ 1:1000 Rabbit De Matteis, TIGEM, Naples 
GAPDH 1:70000 Mouse Biogenesis 
M2 Flag 1:5000 Mouse Sigma,  
GST 1:10000 Mouse De Matteis, TIGEM, Naples 
LPAATδ 1:1000 Rabbit Abcam 
LPAATγ 1:1000 Rabbit Di Tullio, TIGEM, Naples 
Penta-Histidine 1:1000 Mouse Molecular Probes 
GRASP65 C-20 1:5000 Goat Santa-Cruz 
GRASP55 1:1000 Mouse BD Transduction 
PKD2 1:1000 Rabbit Bethyl 
Myc 1:1000 Rabbit Sigma 
BFA 1:500 Rabbit Covalab 
 
2.6.2 Cell growth conditions 
COS7, HeLa TRCN0000154917 and HeLa shRNA TRCN0000127674 cells were 
grown in DMEM supplemented with 4.5 g/l glucose, 2 mM L-glutamine, 1 U/ml 
penicillin and 1 mg/ml streptomycin, and 10% FCS. 
HeLa and Hela CD8+ cells were grown in MEM supplemented with 2 mM L-
glutamine, 50 U/ml penicillin and 50 μg/ml streptomycin, 10% FBS and 100 μM MEM 
non-essential amino-acids solution containing glycine, L-alanine, L-asparagine, L-
aspartic acid, L-glutamic acid, L-proline and L-serine. Complete growth media were 
prepared by diluting stock solutions in DMEM or MEM, and filtering the resulting 
media through 0.2 μm filters. The cells were grown in flasks under a controlled 
atmosphere in the presence of 95% air/ 5% CO2 at 37 °C, until they reached 90% 
confluence. For propagation, the medium was removed, the cells were washed with 
sterile PBS, and 0.25% trypsin solution was added for 2 min to 5 min. The medium 
was then added back to block the protease action of the trypsin, and the cells were 
collected in a plastic tube. After centrifugation for 5 min at 300x g, the pellet of cells 
was resuspended in fresh medium. 
 
2.7 Immunoprecipitation and pull-down experiments 
 
2.7.1 Immunoprecipitation procedures 
 
2.7.1.1 Solutions 
Lysis buffer: 20 mM Tris, pH 7.4, 150 mM KCl, 5 mM MgCl2, 1 mM DTT, 1 mM 
EDTA, 1% (w/v) Triton X-100, protease inhibitor cocktail (Complete Mini EDTA-free, 
Roche) and phosphatase inhibitors (20 mM β-glycerophosphate, 1 mM sodium 
orthovanadate, 10 mM NaF). 
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2.7.1.2 Immunoprecipitation  
All of the following steps were performed on ice or at 4 °C using ice-cold solutions, 
unless otherwise indicated. COS7 cells in 10-cm Petri dishes were transiently 
transfected with 7 μg of each DNA (BARS-pCDNA3, LPAATs-Flag) using 42 μl 
TransIT-LT1 per dish. Twenty-four hours after transfection, the cells were washed 
three times with PBS and lysed using 1 ml lysis buffer/ dish (25 mM Tris, pH 7.4, 150 
mM NaCl, 5 mM EDTA, 5 mM MgCl2, 10 mM NaF, 40 mM β-glycerophosphate, 1 mM 
Na3VO4, 1 mM DTT) supplemented with 1% (v/v) Triton X-100 and protease inhibitor 
mixture (30 min, 4 °C, shaking). The lysates were centrifuged (13,000× g, 10 min, 4 
°C), and the supernatants were assayed for protein concentration (Bradford assay) 
and used fresh.  
 
For BARS immunoprecipitation, 500 μg lysate protein from these COS7 cells was 
brought to 0.2% (v/v) Triton X-100 (final concentration), and incubated with 3 μg anti-
BARS polyclonal, antibody (overnight, 4 °C, shaking). Then 50 μl protein A 
Sepharose beads were added for a further 1 h of incubation (4 °C, shaking). For 
LPAAT immunoprecipitation, 1.2 mg lysate protein from the COS7 cells was brought 
to 0.2% (v/v) Triton X-100 (final concentration), and incubated with 40 μl anti-FLAG 
M2 affinity-gel-purified antibody (2 h, 4 °C, shaking).  
 
For BARS immunoprecipitation in the presence of EcLPAAT, 0.8 mg lysate protein 
from the COS7 cells was brought to 0.2% (v/v) Triton X-100 (final concentration) and 
incubated with 160 μg purified EcLPAAT (2 h, 4 °C, shaking), and then incubated 
with 3 μg anti-BARS polyclonal antibody (overnight, 4 °C, shaking). The immune 
complexes were collected by centrifugation (500× g, 5 min, 4 °C). After three washes 
with lysis buffer with 0.2% Triton X-100, and twice with lysis buffer without Triton X-
100, the bound protein was eluted from the protein A Sepharose beads or from anti-
FLAG M2 affinity-gel-purified antibody by boiling (10 min) in 100 μl Laemmli buffer, 
separated by 10% SDS-PAGE, and subjected to Western blotting via transfer to 
nitrocellulose membranes (Millipore). 
 
The BARS immunoprecipitation from HeLa (CD38+) cells treated with BFA/NAD was 
as described in Colanzi et al. 2013, with some modifications. The cells in 10-cm Petri 
dishes were transiently transfected with plasmids using 42 μl TransIT-LT1 and 7 μg 
of each DNA (BARS-YFP, LPAATδ-Flag) per dish. Sixteen hours after transfection, 
the cells were treated with vehicle alone (DMSO) as a control or with 80 μg/ml BFA in 
the presence of 5 mM NAD+ (2 h, 37 °C). The cells were then washed three times 
with PBS, lysed, and BARS immunoprecipitated. 
 
COS7 cells (1 ×106) in 10-cm Petri dishes were transiently transfected with plasmids 
using 42 μl TransIT-LT1 and 7 μg of each DNA per Petri dish. Twenty-four hours 
after transfection, the cells were washed with PBS, harvested by trypsinisation, 
pelleted and washed three times with PBS. Whole-cell extracts were obtained by 
resuspending and solubilising the cell pellets in lysis buffer on a shaker for 30 min at 
4 °C. The lysates were centrifuged at 13,000x g for 10 min at 4 °C. Then, 500 μg of 
the lysate was incubated overnight with 5 μg mouse anti-Flag antibody, and 30 μl 
Protein-G Sepharose beads (Amersham) were added, with an incubation for an 
additional 1 h at 4 °C. After washing 3 times with lysis buffer and twice with lysis 
buffer without Triton X-100, the bound protein was eluted by boiling the samples for 
10 min in 100 μl Laemmli buffer. The immunoprecipitated proteins and 30 μg total cell 
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lysate were separated on 10% SDS-PAGE gels (16 cm × 32 cm) and transferred 
onto nitrocellulose membranes (Millipore).  
 
For BARS/GRASP55 co-immunoprecipitation, 500 μg lysate protein from HeLa cells 
transfected with 7 μg BARS pCDNA3 and synchronised in G2 or in M phase of the 
cell cycle, was brought to 0.2% (v/v) Triton X-100 (final concentration), and incubated 
with 3 μg anti-BARS polyclonal antibody (overnight, 4 °C, shaking). Then, 50 μl 
protein A Sepharose beads were added for a further 1 h of incubation (4 °C, 
shaking). The immune complexes were collected by centrifugation (500× g, 5 min, 4 
°C). After three washes with lysis buffer with 0.2% Triton X-100, and twice with lysis 
buffer without Triton X-100, the bound protein was eluted from the protein A 
Sepharose beads by boiling (10 min) in 100 μl Laemmli buffer, separated by 10% 
SDS-PAGE, and subjected to Western blotting for GRASP55. 
 
For GRASP65 immunoprecipitation, 500 μg lysate protein from HeLa cells 
synchronised in interphase or in G2 phase of the cell cycle was brought to 0.2% (v/v) 
Triton X-100 (final concentration), and incubated with 2 μg anti-GRASP65 antibody 
(overnight, 4 °C, shaking). Then 50 μl protein A Sepharose beads were added for a 
further 1 h of incubation (4 °C, shaking). The immune complexes were collected by 
centrifugation (500× g, 5 min, 4 °C). After three washes with lysis buffer with 0.2% 
Triton X-100, and twice with lysis buffer without Triton X-100, the bound protein was 
eluted from the protein A Sepharose beads by boiling (10 min) in 100 μl Laemmli 
buffer, separated by 10% SDS-PAGE, and subjected to Western blotting for 
GRASP65 and BARS. 
 
2.7.2 GST and His pull-down assay 
 
2.7.2.1 Solutions 
GST incubation buffer: 20 mM Tris, pH 8.0, 100 mM KCl, 1 mM EDTA, 0.2% Triton X-
100 and protease inhibitor cocktail (Complete Mini EDTA free, Roche). 
GST elution buffer: 100 mM Tris, pH 8.0, 20 mM reduced glutathione, 5 mM DTT. 
His lysis buffer: 50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, 10 mM 
imidazole. 
His wash buffer: 50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, 20 mM 
imidazole. 
His elution buffer: 50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, 250 mM 
imidazole. 
 
2.7.2.2 GST pull-down  
Three micrograms EcLPAAT was incubated with 3 μg GST as control or with 5 μg 
GST-BARS, in GST incubation buffer (20 mM Tris, pH 8.0, 1 mM EDTA, 0.2% Triton 
X-100, 100 mM KCl; overnight, 4 °C, shaking). Then, 30 μl glutathione Sepharose 
beads was added for a further incubation (1 h, 4 °C, shaking). The beads were then 
washed five times with GST incubation buffer, by centrifugation (500× g, 5 min). The 
bound protein was eluted from the glutathione Sepharose beads with GST elution 
buffer (100 mM Tris, pH 8.0, 20 mM glutathione, 5 mM dithiothreitol). The eluted 
protein was separated by 10% SDS-PAGE, and subjected to Western blotting via 
transfer to nitrocellulose membranes (Millipore).  
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For the GST pull-down with BAC-treated BARS, 5 μg GST-BARS was initially 
incubated with buffer alone (20 mM Tris, pH 7.4, 10 mM sucrose) or with 120 μM 
HPLC-purified BAC (Colanzi et al., 2013) (3 h, 37 °C), to allow binding of BAC to 
GST-BARS in the GST incubation buffer. For the GST pull-down with NAD-treated 
BARS, 5 μg GST-BARS was initially incubated with 50 μM NAD+ in GST incubation 
buffer (1 h, RT).  
 
For the BARS-GST pull-down incubated with the GRASP65-myc (provided by the 
Vivek Malhotra Laboratory) overexpressing lysate blocked in G2 and M phase of the 
cell cycle, 1 mg lysate protein from GRASP65-myc tagged expressing cells in 
interphase or blocked in G2 phase of the cell cycle was incubated with GST alone or 
BARS-GST (2 h, 4 °C, shaking). Then, 30 μl glutathione Sepharose beads was 
added for a further incubation (1 h, 4 °C, shaking). The beads were then washed 
three times with GST incubation buffer, by centrifugation (500× g, 5 min). The bound 
protein was eluted from the glutathione Sepharose beads with GST elution buffer 
(100 mM Tris, pH 8.0, 20 mM glutathione, 5 mM DTT). The eluted proteins were 
separated by 10% SDS-PAGE, and subjected to Western blotting via transfer to 
nitrocellulose membranes (Millipore). 
 
2.7.2.3 Histidine pull-down  
His-BARS (20 μg) was incubated for 3 h at 37 °C with buffer alone (20 mM Tris, pH 
7.4, 10 mM sucrose) or with 120 μM HPLC-puriﬁed BAC, to allow binding of BAC to 
His-BARS. The reaction mixture was stopped on ice, and 1 mg lysate protein from 
LPAATδ-Flag expressing cells was incubated with each sample (2 h, 4 °C, shaking). 
Then, 30 μl Ni-NTA agarose beads were added, and the samples were incubated (1 
h, 4 °C, shaking). The beads were then washed three times with lysis buffer at pH 8.0 
supplemented with 0.2% (v/v) Triton X-100 and 20 mM imidazole, by centrifugation 
(700× g, 5 min), and then twice with lysis buffer at pH 8.0 without Triton X-100 but 
supplemented with 20 mM imidazole. The bound protein was eluted from the Ni-NTA 
agarose beads by boiling (10 min) in 100 μl Laemmli buffer, separated by 10% SDS-
PAGE, and subjected to Western blotting via transfer to nitrocellulose membranes 
(Millipore). 
 
2.8 Cell transfection 
 
2.8.1 Plasmids, chemicals and recombinant proteins 
Human LPAAT cDNAs were from ImaGenes GmbH (for subcloning and mutations, 
see Extended Data Table 1); BARS-pCDNA3, BARS-YFP, BARSS147A-YFP, 
BARSS147D-YFP, and BARSD355A-YFP were as previously described in Bonazzi et al. 
(2005), Liberali et al. (2008), Valente et al. (2012). LDLrY18A-GFP was provided by 
R. Polishchuk (TIGEM, Naples, Italy). CI-976 was from Tocris Bioscience, tannic acid 
and BFA from Fluka, protease inhibitors as Complete Mini EDTA-free from Roche, 
cycloheximide, Protein A Sepharose and anti-FLAG M2 affinity gel antibody beads 
from Sigma-Aldrich, oleoyl-LPA from Avanti Polar Lipids, oleoy-1-[l4C]-coenzymeA 
(specific activity, 60 mCi/mmol) and dioleoy-1-[l4C] phosphatidic acid (specific activity, 
140 mCi/mmol) from PerkinElmer, siRNAs from Dharmacon, and TRICH-labelled 
dextran and FITC-labelled dextran from Molecular Probes. NAD+, BAC and HeLa 
(CD38+) cells were as previously described in Colanzi et al. (2013). Ni-NTA agarose 
and glutathione Sepharose beads were from Amersham, Protein A Gold was from 
Cell Microscopy Centre (University Medical Centre Utrecht). Recombinant purified 
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GST and GST-BARS proteins were prepared as described previously (Bankaitis et 
al., 2012), and His-plsC was from Cusabio. 
 
2.8.2 TransIT-LT1-reagent-based cell transfection 
The transfection mixture was prepared by diluting the TransIT-LT1 reagent in 
OptiMEM culture medium and incubating this at RT for 5 min. The DNA was then 
added to the transfection mixture, which was gently shaken, and kept at room 
temperature for another 20 min, to allow the DNA-TransIT-LT1 reagent complex to 
form. The cells were then incubated with the transfection mixture for 12 h to 48 h at 
37 °C, in complete medium without antibiotics. 
 
2.8.3 Lipofectamine LTX-based cell transfection 
The transfection mixture was prepared by diluting the cDNA encoding VSVG-GFP 
(0.5 μg for a 24-well format) and the PLUS solution in OptiMEM medium and 
incubated at RT for 5 min. The Lipofectamine LTX was then added to the transfection 
mixture, which was gently shaken, and kept at RT for another 20 min, to allow the 
DNA-Lipofectamine LTX complex to form. The cells were then incubated with the 
transfection mixture for 1 h at 37 °C in complete medium without antibiotics and then 
shifted for 12 h at 40 °C.  
 
2.8.4 siRNA transfection 
 
2.8.4.1 Materials 
SiRNAs were from Dharmacon (CO, USA), according to the following targets: 14-3-
3γ, D-008844-00; PI4KIIIβ, L-006777-00; BARS, M-008609-01; PAK1, D-003521-03; 
LPAAT3, J-008620-09; LPAAT4, D-009283-03; and si-control nontargeting siRNA 
pool, D-001206-13-20 (siRNA stocks, 20 μM). OptiMEM culture medium and 
Lipofectamine 2000 were from Invitrogen/Gibco (USA). 
 
2.8.4.2 Procedures 
Cells were plated in normal culture medium at a concentration suitable to have 25% 
confluence for transfection. One day later, a transfection mixture was prepared by 
diluting the siRNAs smart pool in OptiMEM medium, and Lipofectamine 2000 with the 
same medium in a separate tube, according to the manufacturer instructions. The 
tubes were gently shaken and incubated for 5 min at RT; after this, the diluted 
siRNAs smart pool was mixed with the diluted Lipofectamine 2000, which were then 
further incubated for 20 min at room temperature, to allow the siRNAs-Lipofectamine 
complex to form. The transfection mixture thus included the smart pool of the 
indicated siRNA sequences or the non-targeting siRNA (or mock transfection as 
control), and this was added to the cells in complete medium without antibiotics, with 
an incubation for an additional 48 h prior to the assays. The efficiency of interference 
was assessed by Western blotting.  
In particular COS7 and HeLa cells were transfected with a non-targeting siRNA or 
with 150 nM of a Smart Pool of LPAATδ/M-009283 or LPAATγ/M-008620 siRNAs, for 
72 h (except for BARS and 14-3-3s siRNAs, where 100 nM of a Smart Pool was used 
for 48 h) using Lipofectamine 2000, according to manufacturer instructions. The 
efficiency of interference was assessed by Western blotting. The treatment with 
Smart Pool siRNAs for LPAATγ (M-008620) and for LPAATδ (M-009283) specifically 
reduce the endogenous protein levels of LPAATγ and LPAATδ (by Western blotting) 
respectively, without affecting the levels of other tested LPAATs. 
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Alternatively, COS7 cells were transfected with the siRNAs (as above) in combination 
for the last 16 h with VSVG-GFP, LDLRY18A-GFP or p75-GFP, and then subjected to 
the specified Golgi-transport assay. For the rescue experiments, COS7 cells were 
transfected with siRNAs for LPAATδ/D-009283-03 (5’-
GCACACGGUUCACGGAGAA-3’, Dharmacon) for 48 h, and transfected for a further 
24 h (using TransIT-LT1) with Flag-LPAATδwt or Flag-LPAATδH96V (both encode an 
siRNA-resistant silent mutation), followed by infection with VSV for the TGN-exit 
assay. 
 
2.9 Cell infection with vesicular stomatitis virus 
 
2.9.1 Materials 
For each infectious stock, the optimal working concentration was experimentally 
defined as the lowest that provided almost 100% infection of COS7 cells, as judged 
by staining for the viral membrane glycoprotein. Cycloheximide (Sigma Chemicals, 
WI, USA) was diluted in PBS to a concentration of 10 mg/ml (as 100× stock), and 
aliquots were stored at –20 °C. 
 
2.9.2 Procedure 
Cells were washed twice in serum-free culture medium and incubated with the diluted 
VSV infectious stock for 45 min at 32 °C. The virus was removed by replacing the 
infection medium with normal complete growth medium, and the cells were kept at 40 
°C in a 95% air/ 5% CO2 incubator for 2 h to allow VSV-G to accumulate in the 
endoplasmic reticulum (ER). After the incubation at 40 °C, the cells were kept at 20 
°C for 2 h with 100 μg/ml cycloheximide, to accumulate VSV-G in the Golgi complex, 
before shifting the temperature to 32 °C to follow Golgi-to-plasma membrane 
transport. 
 
2.10 Electron microscopy 
These procedures were performed by Gabriele Turacchio. 
HeLa cells were transiently transfected with 8 μg plasmid DNA encoding Flag-
LPAATδ for 24 h (using TransIT-LT1). The cells were then processed for cryo-
immunogold EM. For cryo-immunoEM, the specimens were fixed, frozen, and cut 
using a ultramicrotome (Leica EM FC7). Cryo sections were double labelled for 
Golgin-97 (15-nm gold particles) and anti-LPAATδ (10 nm gold particles). EM images 
were acquired using a FEI Tecnai-12 electron microscope.  
 
2.11 Transport assays 
 
2.11.1 VSVG transport from the TGN to the PM 
For the TGN-exit assay of VSV-G, cells were transfected with VSV-G-GFP cDNA, or 
infected with VSV, or injected with the cDNA. The cells were then incubated for 2 h at 
40 °C (12 h only when VSV-G was transfected), followed by 2 h at 20 °C (with 100 
μg/ml cycloheximide) to accumulate VSV-G in the Golgi complex. The temperature 
was then shifted to 32 °C, and the samples were fixed with 4% paraformaldehyde at 
the indicated times. To visualise VSV-G-containing carriers, 0.5% tannic acid was 
added to the VSV-G-infected or VSV-G-expressing cells just before the release of the 
20 °C temperature block during the above TGN-exit assay (as described in 
Polishchuk et al., 2004). The cells were then shifted to 32 °C, fixed and labelled with 
the Cy3-conjugated P5D4 anti-VSVG antibody (for VSV infected cells). TGN-to-
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plasma membrane transport carriers formed during the chase were counted using an 
LSM510 Zeiss confocal microscope. 
The trans-Golgi network (TGN)-exit assay for p75-GFP-transfected, VSVG-GFP-
transfected, and VSV-infected COS7 cells, microinjection, quantification of VSVG-
containing post-Golgi carriers, and quantification of the Golgi-exit of p75 were all 
carried out as reported in Bonazzi et al. (2005) and in Valente et al. (2012). The 
COPI transport assay was performed as previously described in Yang et al. (2005). 
The transport of the endocytosis-defective LDL-GFP receptor (LDLrY18A) was 
performed as described previously in Peters et al. (2006). The CI-976 treatment was 
performed during the VSVG TGN-exit assay, at 50 μM for 10 min, before the 32 °C 
temperature release block and during the 32 °C temperature release block. The anti-
LPAATδ antibody (1 mg/ml) was microinjected 1 h after the beginning of the 20 °C 
incubation in the VSVG transport assay and after 1 h of recovery the cells were then 
processed for wide-field microscopy. Wide-field microscopy was performed as 
described previously in Valente et al. (2012), with some modifications. COS7 cells 
were transfected with siRNAs for LPAATδ (Smart Pool, Lipofectamine 2000), and 
after 48 h, the cells were transfected with VSVG-CFP (overnight, 40 °C) and then 
incubated with 100 g/ml cycloheximide (3 h, 20 °C). The cells were then shifted to 
32 °C (with continued cycloheximide), and followed by fast videomicroscopy. For CI-
976 treatment, COS7 cells were treated with 50 μM CI-976 for 10 min before the shift 
to 32 °C.  
 
2.12 Drug treatments 
 
2.12.1 Ro3306 (Cdk1 inhibitor IV) treatment 
HeLa cells were treated with 9 μM Ro-3306 (Calbiochem) for 20 h, to block them in 
G2 phase of the cell cycle. The cells were then fixed or lysed, or the Ro-3306 was 
washed out, and the cells were left for 1 h in normal medium, to allow their entry into 
M phase. 
 
2.12.2 CI-976 treatment 
COS7 cells were treated with 50 μM CI-976 (Tocris, USA) for 10 min before the 
release of 20 °C temperature block, and also during the chase at 32 °C. The cells 
were fixed after 0, 20 min or 40 min of chase, and assayed for VSV-G transport, or 
alternatively they were analysed by video microscopy. 
 
2.13 LPAAT in vitro assays 
 
2.13.1 Materials 
OleoylLPA, was from Avanti Polar Lipids. [14C]oleoylCoA was from Perkin Elmer. The 
dioleoyl-[14C]PA standard was from Perkin Elmer. Thin layer chromatography (TLC) 
silica gel plates were purchased from Merck. 
 
2.13.2 LPAAT in-vitro assays for BARS 
2.13.2.1 Solutions 
LPAAT reaction buffer: 75 mM Tris-HCl, pH 7.4, 4 mM MgCl2, 1 mM DTT, 4 mM NaF, 
1 mg/ml BSA fatty acid free, 200 μM oleoylLPA, 20 μM [14C]oleoylCoA.  
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2.13.2.2 Preparation of oleoylLPA 
OleoylLPA (10.9 mM, dissolved in chloroform/methanol, 1:1, v/v) was transferred to a 
glass tube, dried under a N2 stream, resuspended in 20 mM Hepes, pH 7.4 (670 μM), 
and sonicated in a water bath. 
 
2.13.2.3 Procedure 
These procedures were performed by Carmen Valente. 
Immunoprecipitated BARS (1.44 μg) or recombinant BARS (1.44 μg) was incubated 
in the LPAAT reaction buffer in a final volume of 100 μl, for 20 min at 25 °C. The 
reaction was stopped on ice by adding 5 μl cold CH3OH/ 1 M HCl (1:1, v/v), vortexed, 
and then the lipids were extracted in 50 μl CHCl3/CH3OH (2:1, v/v). The lower organic 
phase was loaded onto oxalate pretreated TLC plates. The lipids were separated by 
running the TLC plates with CHCl3/CH3OH/NH4OH/H2O (54:42:2.9:9.1, v/v/v/v). The 
radiolabellled spots were quantified by gas ionisation counting (Instant Imager). 
[14C]PA was used as the standard. 
 
2.13.3 LPAATδ in-vitro assay 
 
2.13.3.1 Solutions 
Lysis buffer: 100 mM Tris-HCl, pH 7.4, 5 mM NaCl, 3 mM MgCl2, protease inhibitor 
cocktail (Complete Mini EDTA-free, Roche). 
LPAAT reaction buffer: see section 2.13.2.1 
 
2.13.3.2 Preparation of oleoylLPA 
See section 2.13.2.2 
 
2.13.3.3 Procedure 
These procedures were performed by Carmen Valente. 
All of the following steps were performed on ice or at 4 °C using ice-cold solutions, 
unless otherwise indicated. HeLa cells (1 ×106) in 10-cm Petri dishes were transiently 
transfected with 8 μg plasmid DNA encoding Flag-LPAATδwt or Flag-LPAATδH96V for 
48 h (using TransIT-LT1). Alternatively, the HeLa cells were transfected with siRNAs 
(as above) in combination with Flag-LPAATδwt for 48 h (using Lipofectamine 2000). 
The cells were washed three times with PBS, harvested as 250 μl/ dish in 
homogenisation buffer (100 mM Tris, pH 7.4, 5 mM NaCl, 3 mM MgCl2) 
supplemented with the protease inhibitor mixture, and homogenised (6 pulses, 30% 
amplitude; Branson Digital Sonifier). The lysate was centrifuged at 600× g for 10 min 
at 4 °C. Two micrograms of this post-nuclear supernatant fraction was incubated with 
the LPAAT reaction buffer (75 mM Tris, pH 7.4, 4 mM MgCl2, 1 mM DTT, 4 mM NaF, 
1 mg/ml BSA fatty-acid free, 200 μM oleoylLPA, 20 μM [14C]oleoylCoA) in a final 
volume of 100 μl, for 20 min at 25 °C. The total lipids were extracted by adding 450 μl 
cold CHCl3/CH3OH (2:1, v/v). After 30 min on ice, the samples were centrifuged 
(10,000× g, 5 min). The lower, organic, phase was dried under a stream of nitrogen, 
resuspended in 50 μl CHCl3, and loaded onto a oxalate-pretreated TLC plates. The 
lipids were separated by running the TLC plates with CHCl3/ CH3OH/ 33% NH4OH/ 
H2O (54:42:2.9:9.1; v/v/v/v). The radiolabelled spots were quantified by gas ionisation 
counting (Beta-Imager Systems, Biospace Laboratories). Dioleoyl [14C]PA was used 
as the standard.  
For CI-976 treatment, the post-nuclear fraction from HeLa cells was incubated with 
50 μM CI-976 for 30 min at 25 °C, followed by addition of LPAAT reaction buffer. For 
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anti-LPAATδ antibody treatment, the post-nuclear fraction from HeLa cells was 
incubated with 50 ng anti-LPAATδ affinity-purified polyclonal antibody for 30 min at 
25 °C, followed by addition of LPAAT reaction buffer. For immunopurifed BARS 
treatment, the post-nuclear fraction from HeLa cells was incubated with 500 ng 
immunoprecipitated BARS (purified from rat-brain cytosol with anti-BARS IgG cross-
linked matrix for 30 min at 25 °C, followed by addition of LPAAT reaction buffer. 
In these experiments, LPAATδ-dependent activity (or LPAATδ activity) is defined as 
the activity of LPAATδ-overexpressing extracts minus the activity of LPAATδ-
depleted (or antibody-treated) extracts. In Figures 3.5-3.7, the LPAATδ-independent 
activity (i.e., derived from LPAATδ-depleted or antibody-treated extracts) is indicated 
with the dashed line. The LPAATδ-independent activity was reproducibly 50% of the 
total activity in LPAATδ-overexpressing extracts (as evaluated in more than 20 
independent experiments). 
 
2.14 Immunofluorescence 
 
2.14.1 Materials 
The Alexa 488-, Alexa 546- and Alexa 633-conjugated goat anti-rabbit and anti-
mouse antibodies were from Molecular Probes (OR, USA). 
 
2.14.2 Solutions 
Samples on glass coverslips were mounted on glass microscope slides (Carlo Erba, 
Italy) using Mowiol (20 mg mowiol dissolved in 80 ml PBS, stirred O/N and 
centrifuged for 30 min at 12,000x g). 
 
2.14.3 Sample preparation 
Cells were fixed in 4% paraformaldehyde for 10 min at RT, washed three times in 
PBS, and incubated for 20 min at RT in blocking solution without or with saponin, as 
necessary. The cells were subsequently incubated with the specified antibodies 
diluted in blocking solution (see Table 2.2 for the list and dilutions of the antibodies 
used) for 1 h at RT or O/N at 4 °C. After incubation with the primary antibody, the 
cells were washed three times in PBS and incubated with a fluorescent-probe-
conjugated secondary antibody directed against the constant region of the primary 
IgG molecule, for 45 min at RT. Commonly, Alexa 488-, Alexa 546- or Alexa 633-
conjugated anti-rabbit or anti-mouse goat antibodies were used at a dilution of 1/400 
in blocking solution. After immuno-staining, the cells were washed three times in PBS 
and twice in sterile water, to remove salts. The coverslips were then mounted on 
glass microscope slides (Carlo Erba, IT) with Mowiol. 
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Table 2.2 List of antibodies used in immunofluorescence experiments. 
 
Antibody target Dilution Animal source Supplier source 
BARS (p502) 3 ng/μl Rabbit Corda, IBP, Naples 
TGN46 1:1000 Sheep AbDSerotec 
M2 Flag 1:500 Mouse Sigma 
GM130 1:200 Mouse BD Bioscience 
VSVG 1:1000 Rabbit Bethyl 
VSVG P5D4 Cy3 1:400 Mouse Sigma 
LPAATδ  1:25 Rabbit Sigma 
14-3-3γ 1:100 Rabbit De Matteis, TIGEM, 
Naples 
PI4KIIIβ 1:100 Rabbit De Matteis, TIGEM, 
Naples 
GRASP65 C-20 1:50 Goat Santa-Cruz 
pS10H3 (06-570)  1:100 Rabbit Millipore 
 
2.14.4 Light and immunofluorescence analysis 
Confocal images were acquired using a Zeiss LSM700 confocal microscope system 
(Carl Zeiss, Gottingen, Germany). Fixed cells were analysed using a 63× oil-
immersion objective, maintaining the pinhole of the objective at 1 airy unit, with a 
resolution of 512 × 512 pixels or 1024 × 1024 pixels, and exported as .TIF files. 
 
2.14.5 Fluorescence lifetime imaging microscopy measurements 
This procedure was performed in collaboration with Fabio Formiggini 
COS7 cells were transiently transfected with 0.5 μg BARS-YFP and 2 μg LPAATδ-
CFP using LIPO LTX, according to manufacturer instructions. Sixteen hours after 
transfection, the cells were fixed at steady-state or subjected to the VSVG TGN-exit 
assay, and fixed after 2 h at the 20 °C temperature block. The fluorescence lifetime 
imaging microscopy measurements were performed as previously described in 
Valente et al., 2012. 
 
2.15 Cell-cycle syncronisation 
 
2.15.1. Materials  
Thymidine was from Sigma–Aldrich (Milan, Italy). Dimethylsulfoxide (DMSO) was 
from Carlo Erba (Italy). RO-3306 was from Calbiochem.  
 
2.15.2 Hela-cell syncronisation 
HeLa cells were grown on fibronectin-coated glass coverslips. As soon as they were 
attached to the coverslips, they were incubated in growth medium plus 2 mM 
thymidine for 16 h, and then rinsed and maintained in growth medium for 8 h. The 
cells were then incubated in medium with thymidine for an additional 16 h, before the 
final release of the cell-cycle arrest. At various times after this release (6 h to 13 h), 
the cells were fixed and the DNA was labelled with 2 µg/ml Hoechst 33342 and with 
the appropriate antibodies, depending on the experimental conditions. The mitotic 
index was estimated by measuring the number of cells showing clear mitotic 
(condensed chromosomes) and interphase (diffuse nuclear staining) features. 
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2.15.3 Preparation of mitotic and interphase extracts 
The mitotic and interphase extracts were prepared by the method of Nakagawa et al. 
(1989). NRK cells were grown attached to 20 cm petri dishes and were incubated 
with 2 mM thymidine for 10 h to 12 h, to arrest the cells in S phase. The cells were 
then washed and incubated with 500 ng/ml nocodazole, O/N at 37 °C. This treatment 
arrested the cells in metaphase. The mitotic cells were rounded up by this treatment 
and were easily detached from the Petri dishes using a ‘shake-off’ procedure. The 
cells (95% mitotic index) were washed in PBS followed by mitotic extract buffer 
(MEB, see below), to remove the nocodazole. The cells were pelleted and 
resuspended in twice the packed cell volume with MEB. The cells were allowed to 
swell for 10 min on ice, and then homogenised by repeated passages through a 24 
gauge needle. The homogenised cells were centrifuged in a table-top ultracentrifuge 
at 48,000 rpm for 45 min using a TLS55 rotor. The resulting high-speed supernatant 
(with an approximate protein concentration of 10-12 mg/ml) is termed the mitotic 
extract. This mitotic extract was aliquoted, frozen in liquid nitrogen, and stored at -80 
°C. Interphase extract was prepared from untreated cells by scraping them with a 
rubber policeman. The buffer and homogenisation conditions were identical to those 
of mitotic extract.  
 
The MEB contained 15 mM PIPES (pH 7.4), 50 mM KCl, 10 mM MgCl2, 20 mM β-
mercaptoethanol, 20 mM β-glycerophosphate, 15 mM EGTA, 0.5 mM spermidine, 0.2 
mM spermine, 1 mM DTT, 0.1 mM phenylmethylsulphonyl fluoride, 0.2 mg/ml 
aprotinin, 0.2 mg/ml leupeptin, and 0.2 mg/ml pepstatin. 
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Pagliuso et al. Manuscript under revision 
 
CHAPTER 3 
 
RESULTS 
 
 
3.1 Role of BARS in membrane trafficking 
 
3.1.1 Introduction (Pagliuso et al. Manuscript under revision) 
 
Membrane fission consists of a series of molecular rearrangements by which a 
tubular bilayer joining two membranous compartments undergoes constriction and 
splits in two parts without leakage of contents. It is required for the formation of 
transport vesicles during membrane traffic, organelle partitioning, cell division, and in 
general in the maintenance of the compartmental organisation of endomembranes. 
Fission has been studied intensely during the last decade, and it has been shown to 
be driven by diverse mechanisms (Kozlov, M. M., et al. 2010; Campelo, F et al. 2012; 
Pucadyil, T. J. et al. 2010; Johannes, L. et al. 2010), including membrane insertion of 
amphipathic protein domains (Campelo, F et al. 2012; Boucrot, E. et al 2012; Lee, M. 
C. et al. 2005; Adolf, F. et al 2013), constriction and destabilisation of membranes by 
the mechano-enzyme dynamin (Roux, A. 2013, Ferguson, S. M. & De Camilli, 2012; 
Schmid, S. L. & Frolov, V. A. 2011; Shnyrova, A. V. et al 2013; McMahon, H. T. & 
Boucrot, 2011; Daumke, O., et al 2014), and phase separation of lipid domains 
(Johannes, L. et al. 2010; Lenz, M., et al 2009). Nevertheless, the precise mechanics 
of fission remains elusive, and further analysis of the molecular steps leading to 
fission are still needed. 
We have identified the protein CtBP1-S/BARS (henceforth, BARS) as a key player in 
the fission of post-Golgi tubular/ pleiomorphic carriers (Bonazzi, M. et al. 2005; 
Valente, C. et al 2012; Valente, C., et al 2013), macropinosomes (Liberali, P. et al 
2008; Haga, Y., et al 2009) COPI-dependent transport vesicles (Yang, J. S. et al 
2005; Yang, J. S. et al 2006; Yang, J. S. et al 2008), and the Golgi ribbon, during 
mitosis (Hidalgo Carcedo, C. et al 2004; Colanzi, A. et al. 2007). Structurally, BARS 
belongs to the D-hydroxyacid dehydrogenase family and includes a Rossman fold 
(Nardini, M. et al, 2003) that regulates the interconversion of BARS between two 
(monomeric or dimeric) conformations, which depend on binding to NAD(H) or other 
ligands (Valente, C., et al 2013; Liberali, P. et al 2008; Nardini, M. et al, 2003 Nardini, 
M. et al., 2009; Colanzi, A. et al 2013). This conversion is critical because as a dual-
function protein that controls fission in the cytoplasm and gene transcription in the 
nucleus (Valente, C., et al 2013; Corda, D., et al 2006; Chinnadurai, G. 2009), BARS 
can drive fission as a monomer, while it is fission-incompetent as a dimer (Liberali, P. 
et al 2008, Yang, J. S. et al 2005; Nardini, M. et al, 2003; Colanzi, A. et al 2013).   
The mechanism of action of BARS in fission has been studied mostly in the context 
of the basolateral post-Golgi carrier formation process (Bonazzi, M. et al. 2005 
Valente, C., et al 2013). Here, BARS assembles into a complex that includes Arf, 
frequenin, the phosphoinositide kinase PI4KIIIβ, 14-3-3, and the kinases PKD and 
PAK, and this complex functions to coordinate the budding of carriers with fission 
(Valente, C. et al 2012; Valente, C., et al 2013). To induce fission, BARS must bind 
to 14-3-3 through a phosphorylated serine in its dimerisation surface (Ser147) 
(Valente, C. et al 2012; Valente, C., et al 2013) (see also below). This binding thus  
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locks BARS in its monomeric conformation. However, how 14-3-3-bound BARS 
leads to the lipid rearrangements involved in fission remains unclear.  
Previously, we proposed that BARS-dependent fission involves a lysophosphatidic 
acid (LPA) acyltransferase (LPAAT), based on the following observations: liver Golgi 
membranes contain an LPAAT(s), which upon addition of suitable substrates, 
generates phosphatidic acid (PA) (Weigert, R. et al 1999); PA production correlates 
with the fission of these Golgi membranes(Weigert, R. et al 1999); addition of BARS 
to the Golgi membranes stimulates both PA production and membrane 
fission(Weigert, R. et al 1999); and treatments that inhibit the formation of monomeric 
fission-competent BARS inhibit both LPAAT activity and membrane fission(Yang, J. 
S. et al 2005; Colanzi, A. et al 2013, Weigert, R. et al 1999). We have also reported 
that recombinant BARS is associated with a slow LPAAT activity(Weigert, R. et al 
1999) (see below), which, however, was later shown not to be intrinsic to BARS 
(Gallop, J. L., et al 2005). Moreover, PA metabolism has been implicated in 
membrane transport by other groups, albeit generally based on indirect evidence 
(Liberali, P. et al 2008; Yang, J. S. et al 2008; Asp, L. et al 2009, Siddhanta, A., et al 
2000;  Stace, C. L. et al 2006; Baron, C. L et al 2002; Schwarz, K., et al 2011). 
Based on these findings, here we examined whether BARS might bind to and 
stimulate an endogenous LPAAT, and how this can result in membrane fission. 
There are 11 known LPLATs, four of which have been cloned and shown to transfer 
fatty acids from acyl-CoA to the sn-2 position of LPA, to form PA (LPAATα, β, γ, δ), 
while the others have mixed specificities for LPA and glycerol-phosphate(Yamashita, 
A. et al. 2014; Shindou, H., et al 2013). Here, I show that: BARS interacts with 
LPAAT type δ; this LPAAT localises to the trans-Golgi and to post-Golgi carriers 
precursors; the catalytic activity of LPAATδ is essential for Golgi carrier fission; 
BARS potently stimulates LPAATδ, and this stimulation is essential for carrier fission; 
BARS needs to be incorporated in the PI4KIIIβ–14-3-3γ–BARS complex (Valente, C. 
et al, 2012) to stimulate LPAATδ and induce fission. BARS thus appears to behave 
as an ‘active’ scaffold that binds and stimulates LPAATδ, inducing the LPA to PA 
conversion, and carrier fission. LPA and PA have unique biophysical properties that 
can strongly affect the organisation of lipid bilayers (Kooijman, E. E., et al 2003; 
Kooijman, E. E. et al. 2009, Kooijman, E. E. et al. 2005). Their interconversion might 
have a key role in several cellular fission events. 
 
3.1.2 Results (Pagliuso et al. Manuscript under revision) 
 
3.1.2.1 BARS interacts with a Golgi-localised protein, LPAATδ 
(Pagliuso et al. Manuscript under revision) 
To examine whether BARS interacts with an LPAAT, we first sought to identify the 
LPAATs that localise to the Golgi complex, as most of the BARS-dependent fission 
reactions occur in this organelle (Valente, C. et al. 2012; Valente, C. et al. 2013). We 
Flag-tagged and expressed the available mammalian LPAATs and inspected their 
localisation by immunofluorescence. LPAATγ, LPAATδ and LPAATη localised to both 
the Golgi and the endoplasmic reticulum (ER) (Figure 3.1A), while LPAATβ and 
LPAATε localised to the ER and mitochondria (Figure 3.2; see also Asp, L. et al. 
2009; Siddhanta, A., et al 2000). We thus investigated whether BARS interacts with 
the Golgi LPAATs, by co-expressing BARS with each of these transferases and 
testing for co-immunoprecipitation. BARS co-precipitated with LPAATγ and LPAATδ 
(and vice-versa), but not with LPAATη (Figure 3.1B, C).  
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LPAATγ has been shown to reside at the cis-Golgi and to regulate Golgi structure 
and retrograde transport to the ER (Schmidt, J. A. et al.,2009; Yang, J. S. et al., 
2011) , while LPAATδ has no Golgi-related function that has been characterised to 
date. We examined whether the LPAATδ location might be compatible with post-
Golgi traffic, by studying the intra-Golgi location of this transferase using specific 
antibodies and immuno-electron microscopy (Figure 3.1D) as well as 
immunofluorescence (Figure 3.1E). LPAATδ localised mostly to the trans-Golgi and 
trans-Golgi network (TGN) (Figure 3.1D,E) and to elongated tubules that emanated 
from the Golgi (Figure 3.1E). 
Focusing further on LPAATδ, we asked whether this transferase interacts selectively 
with the monomeric fission-competent form of BARS(Valente, C., et al 2013). As 
noted above, BARS shifts between these two conformations, depending on the 
ligand binding to its Rossman fold. At steady-state, BARS is largely 
monomeric(Colanzi, A. et al  2013; Spanò, S. et al.,1999), while NAD(H) promotes 
dimerisation(Nardini, M. et al. 2003; Nardini, M. et al 2009; Colanzi, A. et al 2013; 
Birts, C. N. et al., 2013) and acyl-CoA promotes monomerisation(Yang, J. S. et al. 
2005; Nardini, M. et al. 2003). Another BARS ligand is BAC (brefeldin–ADP-
ribosylated conjugate), an ADP-ribosylated metabolite of brefeldin A that can also 
bind in the BARS Rossman fold, which generates a covalent bond between its C3 
atom and BARS Arg304 (Colanzi, A. et al 2013). This locks BARS in the dimeric 
inactive conformation very efficiently(Colanzi, A. et al 2013). BAC nearly abolished 
the association between BARS and LPAATδ (Figure 3.1F,G), which indicated that 
BARS binds LPAATδ in its monomeric form. Thus, an LPAAT isoform located in the 
trans-Golgi binds selectively with the fission-active form of BARS. 
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Figure 3.1 BARS interacts with the trans-Golgi localised LPAATδ.  
(A) Representative confocal microscopy images of COS7 cells transfected for Flag-
tagged LPAATγ, LPAATδ and LPAATη, and fixed and processed for 
immunofluorescence with a monoclonal anti-Flag antibody (green) and with a 
polyclonal anti-TGN46 antibody (red; as indicated). (B) BARS immunoprecipitation 
(IP: BARS) of lysate from COS7 cells co-expressing LPAATγ-Flag, LPAATδ-Flag or 
LPAATη-Flag with BARS. Representative Western blotting (antibodies as indicated) 
of total lysate (input) and immunoprecipitated proteins with preimmune-IgG (preim-
IgG) or anti-BARS-IgG (as indicated). IgGH, IgG heavy chain. (C) 
Immunoprecipitation with an anti-Flag antibody (IP: Flag) of lysate from COS7 cells 
co-transfected with LPAATγ-Flag, LPAATδ-Flag or empty vector with BARS. 
Representative Western blotting of total lysate (input) and Flag-immunoprecipitated 
proteins with an anti-Flag monoclonal antibody or the anti-BARS polyclonal antibody 
(as indicated). (D) Representative electron microscopy image of HeLa cells 
transfected with Flag-tagged LPAATδ for 24 h, and fixed and processed for cryo-
immuno-electron microscopy with a monoclonal anti-Golgin 97 antibody (15-nm gold 
particles) and with a polyclonal anti-LPAATδ antibody (10-nm gold particles). (E) 
Representative confocal microscopy images of COS7 cells at steady-state (left) or 
VSV-infected and subjected to the VSVG TGN-exit assay (right). Cells were fixed 
and labelled with a monoclonal anti-LPAATδ antibody (green) and with a polyclonal 
anti-TGN46 antibody (red; left) or a polyclonal anti-VSVG antibody (red; right). Inset, 
right: Magnification of tubular carrier precursors. (F) BARS immunoprecipitation (IP: 
BARS) of control or BFA/ NAD+-treated lysates (±BAC) from HeLa (CD38+) cells with 
preimmune-IgG (preim-IgG) or anti-BARS-IgG. Representative Western blotting with 
anti-BFA polyclonal and anti-Flag monoclonal antibodies of total lysate (input) and 
BARS-immunoprecipitated proteins. The anti-BFA analysed blot (WB: BFA) was then 
reprobed with an anti-BARS monoclonal antibody (as indicated). (G) Histidine pull-
down for His or His-BARS beads of lysates from COS7 cells transfected with 
LPAATδ-Flag. Beads were treated with buffer alone (-) or with HPLC-puriﬁed BAC 
(BAC +), and then incubated with the lysates. The eluted proteins were analysed by 
Western blotting using a monoclonal anti-Flag antibody (top), with the pulled-down 
His-BARS revealed by Ponceau staining (bottom). Molecular weight standards (kDa) 
in (b, c, f, g) are indicated on the left of each panel. Data are representative of three 
independent experiments. Scale bars: 10 μm (a, e), 200 nm (d). (from Pagliuso et al. 
Manuscript under revision) 
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Figure 3.2 Localisation of LPAATβ and LPAATε  
Representative confocal microscopy images of COS7 cells transfected with Flag-
tagged LPAATβ and LPAATε (as indicated) for 24 h, and fixed and processed for 
immunofluorescence with a monoclonal anti-Flag antibody (green; LPAAT) and with 
a polyclonal anti-TGN46 antibody (red; TGN). Scale bars: 10 μm. (from Pagliuso et 
al.  Manuscript under revision) 
 
 
3.1.2.2 Escherichia coli LPAAT binds to the fission-active BARS conformation 
and competes with LPAATδ for BARS binding 
(Pagliuso et al. Manuscript under revision) 
As noted, recombinant BARS purified from Escherichia coli is associated with low 
levels of LPAAT activity (Weigert, R. et al. 1999, Gallop, J. L., et al 2005). We carried 
out a series of pull-down experiments to examine whether purified BARS and E. coli 
LPAAT bind in a specific fashion. His-tagged E. coli LPAAT (which can be prepared 
in a soluble form) (Coleman, J. et al., 1992) showed strong binding with recombinant 
BARS (Figure 3.3A), and this binding was abolished by pretreatments with BAC or 
NAD(H), which indicated that E. coli LPAAT binds selectively to monomeric BARS 
(Figure 3.3B,C). We also asked whether E. coli LPAAT can compete with mammalian 
LPAATδ for binding to BARS (Figure 3.3D), and found this to be the case, which 
indicated that the mammalian and bacterial LPAATs bind to the same BARS domain. 
These data suggest that the LPAATδ and E. coli LPAAT BARS-binding surfaces are 
conserved. Considering the evolutionary distance between the two LPAATs, this is 
somewhat surprising. It is conceivable, however, that the evolutionary ancestors of 
LPAATδ and BARS (namely, the bacterial LPAAT and 3-phospho-glycerate 
dehydrogenase, respectively)( Coleman, J. et al., 1992; Nardini, M. et al. 2003), 
which are both metabolic enzymes, were interactors in an ancient metabolic multi-
enzyme complex (Ovadì, J. & Srere, P. A., 2000), and that this interaction was 
maintained through evolution in different functional contexts. 
These data thus explain our previous observation that BARS purified from E. coli 
associates with an LPAAT activity (Weigert, R. et al 1999), and this provides a 
potentially useful tool (the soluble bacterial enzyme) for the in-vitro reconstitution of 
BARS-dependent fission (see below).  
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Figure 3.3 BARS binds Escherichia coli LPAAT in a conformation-dependent 
fashion. 
Representative GST pull-down assays for GST and GST-BARS beads (as indicated). 
(A) Using recombinant His-tagged E. coli LPAAT (EcLPAAT). (B) Using buffer alone 
(-) or HPLC-purified BAC (BAC +), and then incubated with recombinant EcLPAAT. 
(C) Using buffer alone (-) or 50 mM NAD+ (NAD +), and then incubated with 
recombinant EcLPAAT. The eluted proteins were analysed by Western blotting (top) 
using an anti-histidine antibody to monitor EcLPAAT in (a-c), and an anti-brefeldin A 
antibody (WB: BFA) to monitor ADP-rybosylation, in (b). The pulled-down proteins 
were revealed by Ponceau-S staining (bottom). (D) Representative Western blotting 
with anti-BARS and anti-Flag antibodies for BARS immunoprecipitation (IP: BARS) of 
lysate from COS7 cells transfected with LPAATδ-Flag in the absence (-) or presence 
(EcLPAAT +) of recombinant purifed EcLPAAT with anti-BARS IgG. Total lysate 
(input) and BARS-immunoprecipitated protein are shown. Molecular weight 
standards (kDa) are indicated on the left of each panel. (from Pagliuso et al. 
Manuscript under revision) 
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3.1.2.3 LPAATδ is required for post-Golgi carrier fission 
(Pagliuso et al. Manuscript under revision) 
The TGN localisation and the interaction of LPAATδ with BARS prompted us to 
investigate the role of this enzyme in the BARS-dependent formation of post-Golgi 
carriers (Bonazzi, M. et al. 2005). LPAATδ was silenced with specific small-
interfering (si)RNAs, and the formation of carriers was monitored using the 
temperature-sensitive vesicular stomatitis virus G protein (ts045-VSVG; henceforth, 
VSVG) (Mironov, A. A. et al. 2001) as a traffic marker. The transport of VSVG out of 
the Golgi can be synchronised by accumulating VSVG in the TGN at 20 °C and then 
shifting to the permissive temperature of 32 °C(Bonazzi, M. et al 2005). The 
formation and release of VSVG-containing tubular carriers from the TGN can then be 
visualised and quantified by immunofluorescence microscopy(Bonazzi, M. et al 2005, 
Valente, C. et al. 2012; Polishchuk, R., et al 2004). Depletion of LPAATδ markedly 
reduced the formation of the VSVG-containing carriers (Figure 3.4A); whereas 
depletion of LPAATγ, which is located at the cis-Golgi and is involved in Golgi-to-ER 
traffic (Schmidt, J. A. Et al 2009; Yang, J. S. et al.  2011), had no effect (Figure 3.4B). 
To determine whether the reduction in VSVG-containing carriers was due to inhibition 
of carrier budding or of fission, we monitored carrier formation in living cells 
expressing VSVG-GFP. LPAATδ-depleted cells showed a large number of long (>10 
μm) tubular extensions that contained VSVG-GFP, which appeared to be carrier 
precursors. These elongated out of the Golgi but did not detach, and often retracted 
back into the Golgi area without forming free-moving intermediates. This phenotype 
was similar to that induced by expressing BARS dominant-negative mutants or by 
depleting BARS (we noted that BARS depletion also reduced the number of tubular 
precursors), or by depleting the PI4KIIIβ–14-3-3γ dimer–BARS complex component 
14-3-3γ (Valente, C. et al 2012, Valente, C. et al 2013). Very similar effects were 
induced by microinjection of an affinity-purified antibody against LPAATδ and by the 
general LPAAT inhibitor CI-976 (Drecktrah, D. et al., 2003). These collective 
observations are consistent with an essential role for LPAATδ in carrier fission from 
the Golgi complex. 
We also determined the role of LPAATδ in other traffic steps. We first examined 
retrograde traffic from the Golgi to the ER (which is known to require LPAATγ) 
(Schmidt, J. A. et al 2009; Yang, J. S. et al. 2011), by tracking the retrograde 
transport marker VSVG-KDELR (a fusion of VSVG with the KDEL receptor) (Cole, N. 
B., et al 1998). Transport of VSVG-KDELR was not affected by LPAATδ depletion 
(Figure 3.4C). Secondly, as BARS controls the fission of basolateral but not of apical 
carriers (Bonazzi, M. et al. 2005) , we examined the role of LPAATδ in Golgi export of 
p75 (an apical cargo) (Yeaman, C. et al., 1997) in comparison with export of the low-
density lipoprotein (LDL) receptor (a basolateral cargo, like VSVG) (Matter, K.,et 
al.,1992). Depletion of LPAATδ inhibited export of the LDL receptor (Figure 3.4D), as 
with VSVG, but not that of p75 (Figure 3.4E). Therefore, LPAATδ appears to be 
selectively required for fission of basolateral carriers. 
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Figure 3.4 LPAATδ is required for the fission of basolaterally directed carriers.  
(A, B) Representative images of COS7 cells treated with non-targeting and LPAATδ 
siRNAs (a) or LPAATγ siRNAs (b) before VSV infection and the TGN-exit assay with 
0.5% tannic acid. The cells were fixed following a 20 °C block (0 min) or 30 min after 
the shift to 32 °C, and stained for VSVG-positive post-Golgi carriers. Quantification of 
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VSVG-containing carriers (right). (c) Representative images of COS7 cells treated 
with non-targeting and LPAATδ siRNAs before co-transfected for the last 16 h with 
VSVG-ts045-KDELR-myc. The cells were then examined for the distribution of the 
chimeric KDELR by immunofluorescence microscopy following the shift to the non-
permissive temperature for 30 min. Quantification of ER distribution of the chimeric 
KDELR (right). (A-C) Dotted lines indicate cell borders. (D, E) Representative 
confocal microscopy of COS7 cells treated with non-targeting and LPAATδ siRNAs 
and co-transfected for the last 16 h with the endocytosis-defective LDLR-GFP 
receptor (LDLRY18A-GFP; green) (D) or with a plasmid encoding p75-GFP (green) 
(E). (D) Following a 2 h at 20 °C transport block (0 min) and 60 min after the shift to 
the permissive temperature for transport (32 °C; with cycloheximide to inhibit protein 
synthesis), the cells were fixed and labelled with TGN46 (Golgi marker; red). Insets: 
Enlarged view of merged signals for the Golgi area. (e) Following the 3 h at 20 °C 
transport block (0 min) and 60 min after the shift to the permissive temperature for 
transport (32 °C; with cycloheximide), the cells were fixed and stained for GM130 
(Golgi marker; red). (D, E) Quantification of LDLRY18A-GFP (d) and p75-GFP (e) in 
the Golgi area (right). (A-E) The efficiency of interference was monitored by Western 
blotting of the cell lysates using polyclonal anti-LPAATδ (A, C-E) or polyclonal anti-
LPAATγ (B) antibodies. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is 
shown for the internal protein levels and molecular weight standards (kDa) are 
indicated on the left of each panel (A-E). Data are means ±s.d. of three independent 
experiments. ***P <0.005 (Student’s t-tests). Scale bars, 10 μm. (from Pagliuso et al. 
Manuscript under revision) 
 
 
3.1.2.4 The enzymatic activity of LPAATδ is needed for post-Golgi carrier 
fission. (Pagliuso et al. Manuscript under revision) 
In parallel Dr. Carmen Valente has examined whether the enzymatic activity of 
LPAATδ(Eto, M. et al., 2014) was required for fission, and she assessed LPAATδ 
activity and post-Golgi carrier fission in parallel experiments. To determine the 
LPAAT enzymatic activity, she prepared and incubated post-nuclear supernatants 
with the acyl donor [1-14C]oleoyl-CoA and the acyl acceptor oleoyl-LPA, with [1-
14C]PA measured as the reaction product (see Section 2.13 and Figure 3.5A). Since 
attempts to purify LPAAT enzymes results in activity loss (Eto, M. et al., 2014; Chen, 
Y. Q. et al., 2008), these are the standard conditions used for LPAAT assays (Eto, M. 
et al., 2014; Chen, Y. Q. et al., 2008). Extracts from control cells showed a 
transferase activity that was suppressed by the general LPAAT inhibitor CI-976 
(Figure 3.5B) (Yang, J. S. et al 2011;. Chambers, K.,et al. 2005) A difficulty with 
these extracts is that they contain multiple LPAATs. She therefore designed 
conditions to determine selectively the LPAATδ activity (Figure 3.5A) based on 
suppressing or overexpressing this enzyme. Extracts from LPAATδ-depleted cells 
(Figure 3.5A), or treatment of control extracts with a specific affinity-purified antibody 
against LPAATδ (Figure 3.5B) showed a reproducibly lower (25%) activity than in 
controls (Figure 3.5A,B), which indicated that LPAATδ is responsible for a small 
fraction of the total LPAAT activity. This is indeed in line with the presence of other 
LPAATs and in particular of the abundant glycerolipid synthetic enzymes LPAATα 
and LPAATβ (Yamashita, A. et al 2014; Leung, D. W. 2001). Extracts from LPAATδ-
overexpressing cells showed a 40% increase in LPAAT activity over controls (Figure 
3.5 A-C). This increase was completely inhibited by the antibodies against LPAATδ, 
which decreased the LPAAT activity (Figure 3.5B) to the levels found in the absence 
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of LPAATδ (Figure 3.5A). LPAATδ silencing or overexpression did not affect the 
cellular levels of other LPAATs. Similar data were obtained using [1-14C]palmitoyl-
CoA as acyl donor and arachidonoyl-LPA as acyl acceptor. She thus defined the 
LPAATδ-dependent activity (or LPAATδ activity) as the activity of LPAATδ 
overexpressing extracts (as measured using concentrations of substrates below the 
Km values, see below), minus the activity of LPAATδ depleted (or antibody-treated) 
extracts (Figure 3.5A, B, see dashed line). The Vmax and Km of this LPAATδ activity 
were 38 ±3 nmol/min/mg protein and 58 ±18 μM, respectively, for oleoyl-CoA, and 38 
±1 nmol/min/mg protein and 29 ±1 μM, respectively, for oleoyl-LPA. These rates are 
comparable to those reported for LPAATγ (see Yuki, K., et al 2003). Importantly, 
simple calculations show that they are potentially sufficient, depending on substrate 
availability, to change rapidly and substantially the PA concentrations in the TGN.  
Finally, she asked whether the LPAATδ catalytic activity is required for post-Golgi 
carrier fission. She generated a single-point mutant (LPAATδH96V) in the conserved 
acyltransferase catalytic site of LPAATδ (NHX4D) (Yamashita, A. et al. 2014; Lewin, 
T. M., 1999). Overexpressed LPAATδH96V was indeed devoid of LPAAT activity 
(Figure 3.5C) confirming that LPAATδ is a canonical LPAAT. She then depleted cells 
of LPAATδ, with the consequent inhibition of the post-Golgi transport of VSVG (see 
Figure 3.4A) and expressed either a siRNA-resistant variant of LPAATδ or the 
catalytically dead LPAATδH96V mutant. Only wild-type LPAATδ rescued carrier 
formation, while LPAATδH96V was completely inactive (Figure 3.5D). These data 
indicate that LPAATδ has substantial catalytic activity and that this activity is 
necessary for post-Golgi carrier formation.  
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Figure 3.5 LPAATδ is a canonical LPAAT and its activity is required for post-
Golgi carrier formation.  
(A) Quantification of phosphatidic acid (PA) production in the LPAAT assay for 
postnuclear supernatants from HeLa cells transfected for 48 h with an empty Flag-
vector (Ctr) or with LPAATδ-Flag (LPAATδ), or for 72 h with non-targeting or LPAATδ 
siRNAs. The parentheses indicate the LPAATδ-dependent and independent 
activities. (B) Quantification as in (a), with the post-nuclear fractions also incubated 
with 50 μM CI-976, or polyclonal anti-LPAATδ antibody (anti-LPAATδ IgG), or anti-
preimmune IgG (anti-Preim IgG; as control) for 30 min at 25 °C before LPAAT assay. 
(C) Quantification as in (a), also in parallel with the LPAATδH96V-Flag (LPAATδH96V) 
catalytically inactive mutant. (A-C) The dashed line indicates the level of endogenous 
LPAAT activity not associated with LPAATδ (see text for details). Bottom: 
representative Western blotting with an anti-Flag antibody, for the transfection 
efficiencies of these proteins used for the LPAAT assays. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) is shown for the internal protein levels. 
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Molecular weight standards (kDa) in (a-c) are indicated on the left of each panel. (D) 
Representative images of COS7 cells transfected with non-targeting or LPAATδ 
siRNA (duplex 3; LPAATδ siRNA n°3), and with LPAATδwt-Flag or the LPAATδH96V-
Flag catalytically inactive mutant, and subjected to VSV infection and the TGN-exit 
assay with 0.5% tannic acid. The cells were fixed 30 min after the shift to the 
permissive temperature (32 °C) and processed for immunofluorescence with 
monoclonal anti-Flag and polyclonal anti-VSVG (p5D4) antibodies, to monitor 
formation of VSVG-containing carriers. Dotted lines show cell borders. Asterisks 
represent LPAATδwt-Flag and LPAATδH96V-Flag transfected cells (see inserts for 
staining with anti-Flag antibody; bottom images). Scale bars, 10 μm. Quantification of 
VSVG-positive carriers (right). Data are means ±s.d. of three independent 
experiments. **P <0.01, ***P <0.005 versus control (Student’s t-tests). (from Pagliuso 
et al. Manuscript under revision) 
 
 
3.1.2.5 BARS activates LPAATδ, and this activation is required for carrier 
fission. (Pagliuso et al. Manuscript under revision) 
As BARS and LPAATδ interact (Figure 3.1) and are required for post-Golgi carrier 
fission (see Bonazzi, M. et al. 2005; Valente, C. et al. 2012), Dr. Carmen Valente 
investigated whether BARS might regulate the enzymatic activity of LPAATδ, and 
whether this regulation might be required for carrier fission. She first silenced BARS 
and measured the LPAATδ activity in cell extracts. BARS depletion abolished this 
activity (Figure 3.6A). She then re-expressed BARS in BARS-silenced cells, using a 
siRNA-resistant replacement BARS construct. This nearly completely restored the 
LPAATδ activity (Figure 3.6A). As a specificity control, the above BARS 
manipulations did not affect the cellular levels of LPAATδ or of other LPAATs. These 
results indicate that LPAATδ requires BARS to express its activity. 
She then sought to manipulate the BARS levels acutely in-vitro to exclude 
transcriptional or compensatory effects that might arise in siRNA depletion 
experiments (Valente, C. et al. 2013; Corda, D., et al 2006; Chinnadurai, G. 2009). 
She prepared extracts from LPAATδ-expressing BARS-depleted cells, where 
LPAATδ is inactive (Figure 3.6A), and added immunopurified BARS to the assay 
mixture to reach a final BARS concentration of 5 g/ml (comparable to the levels of 
endogenous BARS) (Bonazzi, M. et al. 2005; Haga, Y., et al 2009). Under these 
conditions, BARS completely restored the LPAATδ-dependent activity (Figure 3.6B) 
(notably, the LPAAT activity associated with the purified BARS was quantitatively 
negligible) (Weigert, R. et al, 1999; Gallop, J. L., et al 2005). She also added BARS 
to control LPAATδ-expressing extracts. This only slightly stimulated the LPAATδ-
dependent activity (Figure 3.6B), which suggested that endogenous BARS is 
sufficient to activate LPAATδ nearly maximally, at least in preparations from 
quiescent cells (i.e., in cells not subjected to a traffic pulse; see below). As a further 
control, she used extracts from cells depleted of BARS and LPAATδ (Figure 3.6B). 
Here, added BARS had no effect on the LPAAT activity, suggesting that other LPAAT 
isoforms are not detectably stimulated by BARS. She also tested the effects of BARS 
on the activity of LPAATγ, a BARS interactor, in experiments similar to those 
designed for LPAATδ (Figure 3.1B,C). Perhaps surprisingly, BARS had no effect on 
this enzyme. These collective data indicate that the stimulatory effects of BARS are 
rapid and apparently selective for LPAATδ, at least under these experimental 
conditions. Notably, these effects correlate well with the ability of microinjected 
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purified BARS to activate the fission of post-Golgi carriers in live cells (Bonazzi, M. et 
al. 2005). 
Further along this line, she sought to inhibit BARS by adding in the LPAAT assay 
mixture a characterised affinity-purified neutralising anti-BARS antibody that when 
microinjected into cells, inhibits carrier fission(Bonazzi, M. et al. 2005; Valente, C. et 
al., 2012; Valente, C., et al., 2005). This antibody inhibited the LPAATδ-dependent 
activity, while preimmune-IgG addition had no effect (Figure 3.6C). Moreover, a 
BARS pre-treatment with BAC, which locks BARS in its dimeric fission-incompetent 
conformation and inhibits the fission of the Golgi ribbon (Colanzi, A. et al.,2013), 
reduced the LPAATδ activity (Figure 3.6D), which indicats that monomeric BARS is 
required for LPAATδ to express its enzymatic activity.   
She further examined the relationship between LPAATδ activity and carrier fission by 
expressing suitable BARS mutants. Previously, she had characterised two single-
point mutants, BARSD355A and BARSS147A, that have dominant-negative effects on 
carrier fission in living cells(Bonazzi, M. et al 2005; Valente, C. et al. 2012). She 
tested these mutants in the LPAATδ activity assay by co-expressing each of them 
with LPAATδ. Both nearly completely inhibited the LPAATδ-dependent activity 
(Figure 3.6E), again without affecting LPAATδ expression levels. As a control, she 
tested the effects of overexpressing wild-type BARS (notably, wild-type BARS and 
the dominant negative mutants showed comparable expression levels in these 
experiments). Overexpressed BARS did not have significant effects on the LPAATδ 
activity in extracts from ‘quiescent’ cells (Figure 3.6E). She noted, however, that 
BARS is recruited to the Golgi during a traffic pulse and activates carrier fission, 
which suggested that active traffic increases the requirement for BARS (Valente, C. 
et al. 2012). In extracts prepared during a traffic pulse, overexpressed BARS 
stimulated the LPAATδ activity (Figure 3.6F). Further, again in traffic-stimulated 
extracts, expression of the fission-active BARSS147D mutant that mimics the activatory 
phosphorylation of BARS on Ser147 (Valente, C. et al. 2012; Liberali, P. et al. 2008; 
Haga, Y., et al 2009) stimulated the LPAATδ activity to an even greater extent 
(Figure 3.6F). 
She finally tested the role of the BARS-14-3-3γ-PI4KIIIβ complex in LPAATδ 
activation. As noted, within this complex, 14-3-3γ binds to phosphorylated S147 in 
the BARS dimerisation interface and is necessary for Golgi carrier fission (Valente, 
C. et al 2012; Valente, C. et al 2013). The LPAATδ activity of cell extracts was 
markedly suppressed by 14-3-3γ depletion (Figure 3.7A), while depletion of other 14-
3-3 isoforms had no effect (Figure 3.7B). Moreover, addition to cell extracts of a 
characterised affinity-purified anti-14-3-3γ antibody (Valente, C. et al 2012) also 
suppressed the LPAATδ activity (Figure 3.7C). These data indicate that 14-3-3γ is 
required for LPAATδ activity, presumably because it stabilises BARS in its 
monomeric fission-competent conformation. 
In summary, a number of treatments based on BARS silencing or overexpression, or 
on the use of BARS mutants as well as anti-BARS antibodies and inhibitors, or on 
manipulations of the BARS-containing complex, stimulated or inhibited LPAATδ 
activity and Golgi carrier fission in completely parallel fashions. These data indicate a 
causal relationship between the BARS-induced LPAATδ activation and membrane 
fission. The stimulation of LPAATδ by BARS is very potent, and appears to occur 
rapidly, most likely via a physical interaction between BARS and LPAATδ during 
assembly of the BARS protein complex required for carrier formation.  
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Figure 3.6 BARS activates LPAATδ and this activation is required for post-
Golgi carrier formation.  
(a) Quantification of phosphatidic acid (PA) production in the LPAAT assay for 
postnuclear supernatants from HeLa cells transfected with empty Flag-vector (Ctr) or 
LPAATδ-Flag (LPAATδ) and with BARS siRNAs for 48 h, and with the last 12 h with 
siRNA-resistant replacement BARS-YFP encoding vector (BARS re-expression). (b) 
Quantification of phosphatidic acid (PA) production in the LPAAT assay for 
postnuclear supernatants from HeLa cells transfected with empty Flag-vector (Ctr) or 
LPAATδ-Flag (LPAATδ) and with BARS siRNAs and/ or LPAATδ siRNAs. Post-
nuclear fractions were incubated with immunopurified BARS (Purified BARS) for 30 
min at 25 °C before LPAAT assay (as indicated). (c) Quantification of phosphatidic 
acid (PA) production in the LPAAT assay for postnuclear supernatants from HeLa 
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cells transfected with empty Flag-vector (Ctr) or LPAATδ-Flag (LPAATδ) for 48 h or 
with LPAATδ siRNAs for 72 h. The anti-BARS polyclonal antibody (anti-BARS IgG) or 
anti-preimmune IgG (anti-Preim IgG, as control) were incubated with the indicated 
post-nuclear fraction for 30 min at 25 °C before the LPAAT assay. (d) Quantification 
of phosphatidic acid (PA) production in the LPAAT assay for postnuclear 
supernatants from HeLa cells transfected with empty Flag-vector (Ctr) or LPAATδ-
Flag (LPAATδ) and with BARS siRNAs for 48 h. Post-nuclear fractions were 
incubated with HPLC-purified BAC (BAC +) or with buffer alone (Buffer -) for 30 min 
at 25 °C before the LPAAT assay (as indicated). (e-f) Quantification of phosphatidic 
acid (PA) production in the LPAAT assay for postnuclear supernatants from HeLa 
cells transfected with: (e) empty Flag-vector (Ctr) or LPAATδ-Flag (LPAATδ) for 48 h 
and the last 12 h with BARSS147A-YFP, BARSD355A-YFP or BARSwt-YFP (as 
indicated); (f) empty Flag-vector (Ctr) or LPAATδ-Flag (LPAATδ) for 48 h and the last 
12 h with BARSwt-YFP, BARSD355A-YFP, BARSS147A-YFP or BARSS147D-YFP (as 
indicated). Cells were infected with VSV, subjected to TGN-exit assay and post-
nuclear fractionations were prepared 10 min after the shift to 32 °C temperature-
block release. The dashed line indicates the level of endogenous LPAAT activity not 
associated with LPAATδ (see text for details). Data are means ±s.d of three 
independent experiments. *P <0.05, **P <0.01, ***P <0.005 versus control (Student’s 
t-test). (from Pagliuso et al.  Manuscript under revision) 
 
 
 
 
 
 
 
 
 79 
 
Figure 3.7 14-3-3, but not other 14-3-3 isoforms, is required for LPAATδ 
activity.  
(A-C) Quantification of phosphatidic acid (PA) production in the LPAAT assay for 
postnuclear supernatants from HeLa cells transfected with the empty Flag-vector 
(Ctr) or LPAATδ-Flag (LPAATδ) plus: (A) transfection with non-targeting siRNAs or 
14-3-3 siRNAs for 48 h (as indicated); (B) transfection with 14-3-3, , ,  and  
siRNAs for 48 h (as indicated); (C) treatment of the post-nuclear supernatant with an 
anti-14-3-3 polyclonal antibody (anti-14-3-3 IgG) or anti-preimmune IgG (anti-Preim 
IgG, as control) for 30 min at 25 °C before the LPAAT assay. (A-C) The dashed line 
indicates the level of endogenous LPAAT activity not associated with LPAATδ (see 
text for details). Bottom: representative Western blotting with an anti-Flag antibody 
(a-c) and with an anti-14-3-3 monoclonal antibody (a) to monitor the transfection of 
LPAATδ and the depletion of 14-3-3 in the lysate used for LPAAT assay. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown for the internal 
protein levels and molecular weight standards (kDa) are indicated on the left of each 
panel. Data are means ±s.d. of three independent experiments. *P <0.05; **P <0.01; 
***P <0.005 versus control (Student’s t-tests). (from Pagliuso et al. Manuscript under 
revision) 
 
 
 
 
3.1.2.6 The BARS–LPAATδ interaction occurs at the Golgi complex in live cells 
(Pagliuso et al. Manuscript under revision) 
The effects of BARS and LPAATδ on the fission of carriers emanating from the Golgi 
suggested that the BARS–LPAATδ interaction occurs at this organelle. To confirm 
this concept directly, we first re-examined the localisation of BARS and of the other 
complex components, 14-3-3γ and PI4KIIIβ, at high resolution. Similar to LPAATδ 
(Figure 3.1D,E), these proteins were all seen to localise at the TGN (Figure 3.8A) as 
well as within the VSVG-containing tubular carrier precursors that form during 
synchronised exit from the TGN (Figure 3.8B). Secondly, we asked whether the 
interaction between BARS and LPAATδ occurs in vivo, as expected. To this end, we 
used a Förster resonance energy transfer (FRET) approach with fluorescence 
lifetime imaging microscopy, which reveals the co-presence of donor and acceptor 
fluorophores within the same complex at a distance of ≤8 nm. We expressed CFP-
LPAATδ as the FRET donor, and BARS-YFP as the acceptor, and monitored the 
FRET. A FRET signal was detected at the Golgi at steady-state (Figure 3.8C) and 
this was markedly increased during a VSVG traffic pulse (Figure 3.8C,D), which is 
consistent with the observation that BARS is recruited to the Golgi during traffic 
(Valente, C. et al 2012). These results indicate that LPAATδ is in a complex with 
BARS in vivo, and that it co-localises at the TGN with BARS, 14-3-3γ and PI4KIIIβ, in 
agreement with the BARS–LPAATδ co-precipitation data (Figure 3.1B, C). 
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Figure 3.8 BARS colocalises with 14-3-3 and PI4KIII at the TGN and in carrier 
precursors, and interacts with LPAATδ at the Golgi.  
(A, B) Representative images of COS7 cells at steady state (A) or VSV-infected and 
subjected to the VSVG TGN-exit assay (B). The cells were fixed and labelled with 
polyclonal anti-BARS, anti-14-3-3γ or anti-PI4KIIIβ (a-b; green) antibodies, and with 
an anti-TGN46 antibody (a; red) or a monoclonal anti-VSVG antibody (b; red). Insets, 
right: Magnification of the tubular carrier precursors in the Golgi area. Scale bars: 10 
μm (a, b). (C, D) FLIM-FRET of COS7 cells transfected with LPAATδ-CFP and 
BARS-YFP. (C) Quantification of FLIM-FRET efficiency for the Golgi area at steady 
state and during a VSVG traffic pulse (as indicated). Data are means ±s.d. (n = 20 
cells/condition). ***P <0.005 (Student’s t-tests) versus steady-state. (D) Distribution of 
fluorescence lifetimes measured in the Golgi area for LPAATδ-CFP alone (red) and 
with BARS-YFP (blue). Co-expression of BARS-YFP produces a shift towards 
shorter lifetimes (hence indicating FRET between LPAATδ-CFP and BARS-YFP). 
The average fluorescence lifetime of LPAATδ-CFP was 2.31 ns for LPAATδ-CFP 
alone, and 2.10 ns for LPAATδ-CFP with BARS-YFP. Inset: Representative FLIM-
FRET images of cells (top: LPAATδ-CFP, blue; BARS-YFP, green; bottom: LPAATδ-
CFP alone, blue). (from Pagliuso et al. Manuscript under revision) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 82 
 
3.2 Role of BARS in mitosis 
 
3.2.1 Introduction 
As indicated above, inhibition of Golgi fragmentation results in the arrest of the cell 
cycle at the G2 phase, which suggests that a ‘Golgi checkpoint’ monitors the mitotic 
partitioning of the Golgi membranes (Hidalgo Carcedo et al., 2004; Persico et al., 
2010; Sutterlin et al., 2002). 
The membrane fission factor BARS controls the disassembly of the Golgi stacks by 
severing the tubular networks of the non-compact zones (Colanzi et al., 2007). 
Interfering with BARS activity in a semi-intact Golgi fragmentation assay results in 
groups of large tubular–vesicular–saccular networks of Golgi membranes that are 
continuous and are localised in the pericentriolar region (Colanzi et al., 2007). As 
discussed in Chapter 1, section 1.5, BARS is required for several membrane-fission 
processes (Bonazzi et al., 2005; Valente et al., 2012; Yang et al., 2011). However, 
Golgi membranes are only fragmented in late G2, which indicates that BARS is 
specifically activated in G2 to promote Golgi-ribbon severing. Several molecules 
involved in the initial Golgi-ribbon unlinking during mitosis have been identifed. In 
particular, Golgi fragmentation is inhibited by blocking the GRASP65 and GRASP55 
proteins with a cell-cycle arrest at the G2 stage (Preisinger et al., 2005; Feinstein and 
Linstedt, 2007; Duran et al., 2008).  
It has been demonstrated that GRASP55 is a mitogen-activated protein kinase 
(MAPK) substrate that is phosphorylated by ERK2 both in vitro and in vivo (Jesch et 
al., 2001). Moreover, GRASP55 is connected to the Raf-MEK1 pathway, although it 
is not clear whether this occurs through the ERK2 protein or its splice variant 
ERK1b/1c (1b in mouse; 1c in humans). ERK2 and ERK1b/1c have been 
demonstrated to be recruited to the Golgi membranes, to be activated by MEK1, and 
to be required for Golgi fragmentation and for cell entry into mitosis (Abershold et al., 
2004; Shaul and Seger, 2006). Moreover, Kienzle (2012) and colleagues have 
recently demonstrated that PKD is an important player in Golgi mitotic checkpoint 
control. PKD can activate the Raf1-MEK1-ERK1c pathway during G2, and GRASP55 
has been reported to be a putative downstream target of this pathway. 
On the other hand, it has been demonstrated that GRASP65 can be phosphorylated 
by Cdk1 and Plk1 during mitosis, and that this phosphorylation changes the 
GRASP65 conformation, leads to its de-oligomerisation, and to Golgi cisternae 
unlinking (Wang et al., 2005). After mitosis, GRASP65 is dephosphorylated and 
reforms trans-oligomers and re-stacks Golgi cisternae. 
With the aim to clarify the molecular mechanisms of BARS-dependent membrane 
fission in mitosis, my study also focussed on the identification of possible links 
between BARS and the two well-characterised GRASP55-dependent and GRASP65-
dependent mitosis-activated pathways. 
 
3.2.2 Results 
To examine whether BARS interacts with GRASP55 amd/or GRASP65, I first 
immunoprecipitated BARS from HeLa cells that were transfected with BARS 
pCDNA3 synchronised and blocked in G2 or in M phase of the cell cycle, 
usingtreatment with Ro3306, a Cdk1 specific inhibitor. The immunoprecipitated 
proteins were analysed by Western blotting with an anti-GRASP55 antibody. As 
shown in Figure 3.9A, endogenous GRASP55 specifically co-precipitated with BARS 
in both G2 and M-phase synchronised cells. 
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Conversely, using the same approach, upon GRASP65 immunoprecipitation, BARS 
did not co-precipitate, neither in G2 nor M-phase synchronised cells (Figure 3.9B). 
Similar data were obtained in pull-down experiments. Purified recombinant GST-
BARS did not pull down GRASP65 from GRASP65-myc overexpressing cells lysates 
blocked in the G2 and M phases (Figure 3.9C). 
Collectively, these data indicate that BARS interacts with GRAP55, but not with 
GRASP65.  
To further understand the functional role of this interaction between GRASP55 and 
BARS, I first analysed whether the localisation of BARS at the Golgi complex is 
GRAP55-mediated, using immunofluorescence. Taking advantage of the use of Hela 
cells that were under stable depletion of GRASP55 or GRASP65, I found that the 
Golgi localisation of BARS is neither GRASP55-mediated nor GRASP65-mediated 
(Figure 3.10A). 
 
 
 
 
Figure 3.9 BARS interacts with GRASP55 but not with GRASP65. 
(A). BARS immunoprecipitation (IP:BARS) of lysate from HeLa cells synchronised in 
G2 or M phase (as indicated). Ponceau staining or representative Western blotting 
(WB; antibodies as indicated) of total lysate (input) and co-immunoprecipitated 
protein (as indicated). (B) Immunoprecipitation with an anti-GRASP65 antibody 
(IP:GRASP65) of lysate from HeLa cells synchronised in interphase or G2 phase (as 
indicated). Representative Western blotting of total lysate (input) and GRASP65-
immunoprecipitated proteins with an anti-GRASP65 antibody or the anti-BARS 
antibody (as indicated). (C) Pull-down assay of GST and GST-BARS (as indicated) 
with GRASP65 overexpressing cell lysate synchronised in interphase (I) or G2 (as 
indicated). Elution with reduced glutathione (1,2), or sample buffer (3) followed by 
Western blotting with an anti-GRASP65 antibody (top), with pulled-down proteins 
revealed by Ponceau-S staining (bottom). 
A)      B)  
                                          
                                   C)  
 84 
 
 
 
 
However, based on the demonstrated of Kienzle and colleagues that PKD has a role 
in the activation of GRASP55, I investigated whether the Golgi localisation of BARS 
can be affected by PKD knock-down. Interestingly, as shown in Figure 3.10B, the 
Golgi pool of BARS was reduced in PKD knock-down cells, compared to non-
targeting treated cells. 
Additionally, I have shown that the Golgi localisation of BARS is also PtdIns4P-
mediated. Indeed, treatment with PIK93, a PI4KIIIβ specific inhibitor, strongly 
reduced the Golgi localisation of BARS (Figure 3.10C). These data are in line with 
the ability of BARS to bind PtdIns4P in vitro (Yang et al., 2008) and with its co-
localisation with a Golgi pool of PtdIns4P (data not presented in this thesis). I have 
also shown that the PI4KIIIβ-mediated PtdIns4P pool affects the interaction between 
BARS and LPAATδ. As shown in (Figure 3.10D), cell treatment with PIK93 reduced 
the co-precipitation between LPAATδ and BARS. 
Collectively these results suggest a possible link between BARS and the PKD-Raf-
MEK1-Erk-GRASP55 signalling pathway in mitosis. However, further studies are 
needed to clarify how BARS is specifically involved in this pathway, what is the 
molecular mechanism of BARS in mitosis, and whether a lipid metabolic enzyme and 
its product is involved in BARS-mediated membrane fission in mitosis. 
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Figure 3.10 BARS localises at the Golgi complex in a PtdIns4P-dependent 
manner. 
(A). Representative confocal microscopy images of HeLa wild-type (wt) cells, 
GRASP55 stable depleted cells (shRNA74), and GRASP65 stable depleted cells 
(shRNA17), fixed and processed for immunofluorescence with an anti-GM130 
antibody (red), DAPI (blue), and an anti-BARS antibody (green; as indicated). (B) 
Representative confocal microscopy images of HeLa wt cells, treated with non-
targeting (siRNA ctr) or PKD2 siRNA (lower panel), fixed and processed for 
immunofluorescence with an anti-BARS antibody (green; as indicated). (C) 
Representative confocal microscopy images of COS7 cells treated with 1 μM PIK-93 
or with DMSO (as control) for 20 min, fixed and labelled with an anti-BARS antibody 
(green) and an anti-TGN46 antibody (red) (D) BARS immunoprecipitation (IP:BARS) 
of lysates from COS7 cells transfected with LPAAT4-flag and BARS and incubated 
without (-) or with (+) PIK-93. Analysis by Western blotting (antibodies as indicated) 
of total lysate (input), and immunoprecipitated material (IP). 
 
 
A) B)  
 
 
C)          D)  
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CHAPTER 4 
 
DISCUSSION 
 
In the first part of my PhD thesis, I demonstrated that BARS induces fission of 
basolaterally directed post-Golgi carriers through its interaction and activation of 
LPAATδ, a member of the acyl-transferase family that converts LPA into PA. I also 
showed that this LPA-PA interconversion has a role in BARS-dependent fission. 
Transport carriers have an essential role in intracellular membrane transport. These 
carriers shuttle from donor to acceptor compartments, through budding and fission 
from the former, and fusion with the latter. They can be divided in two main groups: 
small coated (or coat-dependent) vesicles (e.g., COPI or COPII vesicles, clathrin-
dependent vesicles) and large pleiomorphic carriers or PGCs. BARS is required for 
the fission of these PGCs (Bonazzi et al., 2005; Valente et al., 2012), as well as for 
other fission events, including fission of the macropinocytic cup during EGF-
stimulated macropinocytosis (Liberali et al., 2008), fission of COPI vesicles for 
retrograde trafficking from the Golgi to the ER (Yang et al., 2005), and also for the 
fission-fragmentation of the Golgi complex during mitosis (Hidalgo Carcedo et al., 
2004). Even though the involvement of BARS in these pathways has been 
extensively characterised, the mechanism of action of BARS-induced membrane 
fission is still under investigation.  
On the basis that we previously identified BARS as a key component of a protein 
complex that is required for post-Golgi carrier fission (Valente et al., 2012), in this 
thesis the question I wished to address was how BARS drives membrane fission, and 
if this function requires specific interaction/ regulation through an LPAAT enzyme.  
Here, I have shown that BARS interacts with two Golgi-localised LPAATs, namely 
LPAATγ and LPAATδ, and in particular that LPAATδ interacts with the monomeric 
fission-competent form of BARS. Indeed, LPAATγ has been recently suggested to 
localise at the cis-side of the Golgi complex and to have a role in the retrograde 
membrane trafficking, whereas nothing is known about LPAATδ. We have used 
immuno-electron microscopy studies to demonstrated that LPAATδ localises mostly 
to the trans-Golgi and the TGN, so I have analysed its possible role in PGC 
formation. LPAATδ depletion impairs both VSVG and LDLr transport from the TGN to 
the PM, while it does not affect p75 apical transport or retrograde transport from the 
Golgi to the ER. Therefore, LPAATδ, like BARS, is selectively required for fission of 
basolateral carriers. 
In agreement with published data (Eto et al., 2014), Dr. Valente has shown that 
LPAATδ is an LPA acyltransferase, the activity of which can be abrogated by 
mutagenesis of three conserved amino acids in its catalytic core (Schmidt and 
Brown, 2009). The data reported here show that when LPAATδ activity is blocked, 
the exit of the cargo reporter VSVG from the Golgi complex is heavily impaired. 
Indeed, when the LPAATδ activity was reduced by either overexpression of a 
catalytically inactive mutant or by injection of an anti-LPAATδ antibody, VSVG 
trafficking was inhibited, and a fission-defect phenotype was observed. Strikingly, 
when the LPAATδ activity is inhibited using a general LPAAT inhibitor, CI976, there 
was massive tubulation of the Golgi complex, which suggests that LPAAT activity is 
involved in fission.  
Collectively, these data show that LPAATδ is involved in Golgi dynamics, with a clear 
role in fission at the TGN. However, Dr. Valente has also shown that BARS activates 
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LPAATδ and that this activation is important for PGC fission. In particular, when 
BARS is inhibited by the addition in the LPAAT assay mixture of a well-characterised 
affinity-purified neutralising anti-BARS antibody, or by siRNA treatment, or by pre-
treatment of BARS with BAC (which locks BARS in its dimeric fission-incompetent 
conformation and inhibits the fission of the Golgi ribbon), there was a reduction in the 
LPAATδ activity. This indicates that monomeric BARS is required for LPAATδ to 
express its enzymatic activity.  
These studies have demonstrated that a new enzyme, LPAATδ, and its product PA, 
have crucial roles in membrane trafficking, and specifically at the fission step. 
In the second part of my PhD thesis I analysed the fission-inducing property of BARS 
in Golgi partitioning in mitosis. The molecular mechanism by which BARS acts in 
mitosis is still unclear. However, here I have provided evidence that BARS can 
interact with GRASP55 (but not with GRASP65), in both the G2 and M phases of the 
cell cycle. Moreover, I have also showed that the localisation of BARS at the Golgi 
complex is PKD-mediated and not GRASP55 or GRASP65 dependent.  
PKD is required for mitotic fragmentation of Golgi membranes in late G2 phase of the 
cell cycle and for mitotic entry, through activation of the Raf1-MEK1-ErK1c pathway. 
A putative downstream target of this signalling pathway is the Golgi stacking protein 
GRASP55. Indeed, inhibition of GRASP55 resulted in inhibition of the severing of the 
Golgi ribbon and arrest of the cell cycle at the G2 stage. Moreover, it has been 
demonstrated that PKD phosphorylates PI4KIIIβ at the Golgi complex, which in turn 
is involved in post-Golgi carrier fission. Indeed, the PKD-mediated PI4KIIIβ 
phosphorylation increases the local production of PtdIns4P, which supports the 
budding of tubular carrier precursors, most likely through recruitment of PtdIns4P 
binding proteins. One of these PtdIns4P binding proteins might be BARS. Indeed, the 
PI4KIIIβ specific inhibitor, PIK93, reduces the localisation of BARS at the Golgi 
complex, and in turn, the interaction between BARS and LPAATδ. 
Collectively these data show the identification of key components, as proteins and a 
lipid metabolic enzyme, involved in the BARS-mediated fission process. Specifically, 
these data reveal the role of LPAATδ in BARS-dependent post-Golgi carrier fission, 
and identify GRASP55 as a component of BARS-dependent Golgi-ribbon unlinking in 
mitosis. 
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CHAPTER 5 
 
CONCLUSIONS 
 
What is the relevant biotechnological approach of this study? 
The CtBP proteins have been linked to tumorigenesis and tumour progression. As 
transcriptional co-repressors, the CtBPs can promote epithelial-mesenchymal 
transition and act as apoptosis antagonists, while as fission-inducing proteins, they 
control the Golgi checkpoint in mitosis, and thus cell-cycle progression.  
To define the molecular mechanisms involved in the dual action of the CtBPs, and in 
particular of BARS in tumorigenesis and tumour progression, several molecules that 
can functionally modulate BARS are under investigation in our laboratories. However, 
a novel anti-cancer strategy might be developed based on the functional modulation 
of key BARS interactors. 
I have contributed to the identification of a novel LPAAT family member, LPAATδ, 
that localises at the Golgi complex, where it catalyses the acylation of LPA to form 
PA. BARS activates LPAATδ, which results in an increase in PA production at the 
Golgi complex. PA is an important membrane remodelling metabolite that is involved 
in membrane transport, as well as a key second messenger that can modulate cell 
survival and proliferation, and tumour progression. Indeed, PA has been shown to 
bind Raf1 kinase and to activate the Ras-Raf signalling pathway, which in turn, 
regulates cell proliferation and apoptosis. Additionally, PA is required for mTOR 
activity, the mammalian target of rapamycine, which is implicated in signals that 
suppress apoptosis in cancer cells (Rizzo et al., 2000; Fang et al, 2001; Foster et al 
2001). 
Among the several LPAATs isoforms, LPAATβ is the most well studied in cancer. It is 
overexpressed in several tumours (e.g., lung, breast, colon, prostate, leukaemia, 
lymphoma), and its activity is associated with more aggressive tumour phenotypes 
(Scott et al., 2014). The knock-down (by isoform-specific siRNAs) or inhibition (by 
small-molecule inhibitors) of LPAATβ induces a G2/M cell-cycle checkpoint block, 
followed by growth arrest and apoptosis. These data indicate that LPAATβ is a 
potential target for several tumours (Coon et al., 2003; Pagel et al., 2005; la Rosèe et 
al., 2006; Niesporek et al., 2005; Rastegar et al., 2010). Moreover, a specific 
LPAATβ inhibitor, CT-32228, was recently identified that can inhibit proliferation of 
several cancer cell lines. Unfortunately, in vivo, this compound induced higher 
toxicity, making it unsuitable for clinical development. 
The data obtained in this study demonstrate the relevance of LPAATδ-mediated PA 
production in membrane fission, a process that is required for membrane trafficking 
as well as for the Golgi partitioning in mitosis in the G2 phase of the cell cycle. 
Starting from these observations the role of the LPAATδ enzyme can be investigated 
in mitosis and thus in cell-cycle regulation, with the aim to identify chemical inhibitors 
that can selectively target and inhibit it in cancer cells overexpressing LPAATδ. 
Indeed, as well as LPAATβ, LPAATδ is also highly expressed in several tumours. 
LPAATδ-specific inhibitors can be designed and synthesised based on the molecular 
analogy with LPAATβ and its specific inhibitors (e.g., CT-32228), and their role in 
BARS-mediated tumorigenesis and tumour progression will be analysed.  
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